JP2014034545A - External preparation for skin - Google Patents
External preparation for skin Download PDFInfo
- Publication number
- JP2014034545A JP2014034545A JP2012176586A JP2012176586A JP2014034545A JP 2014034545 A JP2014034545 A JP 2014034545A JP 2012176586 A JP2012176586 A JP 2012176586A JP 2012176586 A JP2012176586 A JP 2012176586A JP 2014034545 A JP2014034545 A JP 2014034545A
- Authority
- JP
- Japan
- Prior art keywords
- group
- skin
- carbon atoms
- external preparation
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 57
- 239000000178 monomer Substances 0.000 claims abstract description 67
- 229920001577 copolymer Polymers 0.000 claims abstract description 57
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 18
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 15
- 125000004432 carbon atom Chemical group C* 0.000 claims description 42
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 17
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 13
- 125000000217 alkyl group Chemical group 0.000 claims description 13
- 239000002537 cosmetic Substances 0.000 claims description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 9
- 125000001931 aliphatic group Chemical group 0.000 claims description 8
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 7
- 125000002252 acyl group Chemical group 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 7
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 claims description 6
- 125000002947 alkylene group Chemical group 0.000 claims description 4
- 125000004429 atom Chemical group 0.000 claims description 3
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 3
- 150000001735 carboxylic acids Chemical class 0.000 claims 2
- 230000008591 skin barrier function Effects 0.000 abstract description 18
- 230000009471 action Effects 0.000 abstract description 11
- 125000000837 carbohydrate group Chemical group 0.000 abstract 1
- -1 maltotriose Chemical compound 0.000 description 91
- 210000003491 skin Anatomy 0.000 description 66
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 38
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 28
- 239000000243 solution Substances 0.000 description 28
- 238000003756 stirring Methods 0.000 description 27
- 238000004519 manufacturing process Methods 0.000 description 25
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 230000000052 comparative effect Effects 0.000 description 17
- 239000002202 Polyethylene glycol Substances 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 16
- 229920001223 polyethylene glycol Polymers 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 235000019441 ethanol Nutrition 0.000 description 15
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 14
- 239000006210 lotion Substances 0.000 description 14
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 13
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 12
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 11
- 239000011248 coating agent Substances 0.000 description 10
- 238000000576 coating method Methods 0.000 description 10
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 235000014113 dietary fatty acids Nutrition 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000000194 fatty acid Substances 0.000 description 9
- 229930195729 fatty acid Natural products 0.000 description 9
- 238000006116 polymerization reaction Methods 0.000 description 9
- 230000000638 stimulation Effects 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 229910001873 dinitrogen Inorganic materials 0.000 description 8
- 150000002430 hydrocarbons Chemical group 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- 238000006467 substitution reaction Methods 0.000 description 8
- KUQRLZZWFINMDP-BGNLRFAXSA-N 2-[(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O KUQRLZZWFINMDP-BGNLRFAXSA-N 0.000 description 7
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 7
- 239000004359 castor oil Substances 0.000 description 7
- 235000019438 castor oil Nutrition 0.000 description 7
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 7
- 229920001296 polysiloxane Polymers 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000006096 absorbing agent Substances 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 229960005150 glycerol Drugs 0.000 description 5
- 229920001451 polypropylene glycol Polymers 0.000 description 5
- 210000000434 stratum corneum Anatomy 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 4
- 230000004888 barrier function Effects 0.000 description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 230000007123 defense Effects 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 229920002907 Guar gum Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000003125 aqueous solvent Substances 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 235000010417 guar gum Nutrition 0.000 description 3
- 239000000665 guar gum Substances 0.000 description 3
- 229960002154 guar gum Drugs 0.000 description 3
- 239000002649 leather substitute Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 229960004063 propylene glycol Drugs 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 2
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- SHZIWNPUGXLXDT-UHFFFAOYSA-N caproic acid ethyl ester Natural products CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000003999 initiator Substances 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- ZWRUINPWMLAQRD-UHFFFAOYSA-N nonan-1-ol Chemical compound CCCCCCCCCO ZWRUINPWMLAQRD-UHFFFAOYSA-N 0.000 description 2
- ZQTHOIGMSJMBLM-BUJSFMDZSA-N pangamic acid Chemical compound CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O ZQTHOIGMSJMBLM-BUJSFMDZSA-N 0.000 description 2
- 108700024047 pangamic acid Proteins 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- DOKHEARVIDLSFF-UHFFFAOYSA-N prop-1-en-1-ol Chemical group CC=CO DOKHEARVIDLSFF-UHFFFAOYSA-N 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 230000036572 transepidermal water loss Effects 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- FPJHWYCPAOPVIV-VOZMEZHOSA-N (2R,3S,4R,5R,6R)-6-[(2R,3R,4R,5R,6R)-5-acetamido-2-(hydroxymethyl)-6-methoxy-3-sulfooxyoxan-4-yl]oxy-4,5-dihydroxy-3-methoxyoxane-2-carboxylic acid Chemical compound CO[C@@H]1O[C@H](CO)[C@H](OS(O)(=O)=O)[C@H](O[C@@H]2O[C@H]([C@@H](OC)[C@H](O)[C@H]2O)C(O)=O)[C@H]1NC(C)=O FPJHWYCPAOPVIV-VOZMEZHOSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- 125000005919 1,2,2-trimethylpropyl group Chemical group 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical group CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- TXHZNLCKXHJYNX-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound COCCOCCOCCOCCOCCOCCOCCOCCOCCOC(=O)C(C)=C TXHZNLCKXHJYNX-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- WDQMWEYDKDCEHT-UHFFFAOYSA-N 2-ethylhexyl 2-methylprop-2-enoate Chemical compound CCCCC(CC)COC(=O)C(C)=C WDQMWEYDKDCEHT-UHFFFAOYSA-N 0.000 description 1
- NCLNAHJFXIKYBY-UHFFFAOYSA-N 2-hexyldecyl 16-methylheptadecanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C NCLNAHJFXIKYBY-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- KLPCZNSIPDGAJJ-UHFFFAOYSA-N 2-methoxy-3,3-dimethyl-1-phenylbutan-1-one Chemical compound COC(C(C)(C)C)C(=O)C1=CC=CC=C1 KLPCZNSIPDGAJJ-UHFFFAOYSA-N 0.000 description 1
- HFCUBKYHMMPGBY-UHFFFAOYSA-N 2-methoxyethyl prop-2-enoate Chemical compound COCCOC(=O)C=C HFCUBKYHMMPGBY-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- HJESVTJHPLATNR-UHFFFAOYSA-N 3,3-dimethylbutan-2-yl prop-2-enoate Chemical compound CC(C)(C)C(C)OC(=O)C=C HJESVTJHPLATNR-UHFFFAOYSA-N 0.000 description 1
- MSPJNHHBNOLHOC-UHFFFAOYSA-N 3,3-dimethylcyclopropane-1,2-dicarboxylic acid Chemical compound CC1(C)C(C(O)=O)C1C(O)=O MSPJNHHBNOLHOC-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- SXIFAEWFOJETOA-UHFFFAOYSA-N 4-hydroxy-butyl Chemical group [CH2]CCCO SXIFAEWFOJETOA-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- PNGXUJXDFJQYAF-UHFFFAOYSA-L C(CC(O)(C(=O)[O-])CC(=O)O)(=O)O.[K+].C(CC(O)(C(=O)O)CC(=O)O)(=O)[O-].[K+] Chemical compound C(CC(O)(C(=O)[O-])CC(=O)O)(=O)O.[K+].C(CC(O)(C(=O)O)CC(=O)O)(=O)[O-].[K+] PNGXUJXDFJQYAF-UHFFFAOYSA-L 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- HFBMWMNUJJDEQZ-UHFFFAOYSA-N acryloyl chloride Chemical compound ClC(=O)C=C HFBMWMNUJJDEQZ-UHFFFAOYSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 description 1
- XYLMUPLGERFSHI-UHFFFAOYSA-N alpha-Methylstyrene Chemical compound CC(=C)C1=CC=CC=C1 XYLMUPLGERFSHI-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- TXGJTWACJNYNOJ-UHFFFAOYSA-N hexane-2,4-diol Chemical compound CCC(O)CC(C)O TXGJTWACJNYNOJ-UHFFFAOYSA-N 0.000 description 1
- OGEMCJNRDGZFQF-UHFFFAOYSA-N hexyl 2-benzoyl-4-(diethylamino)-3-hydroxybenzoate Chemical compound CCCCCCOC(=O)C1=CC=C(N(CC)CC)C(O)=C1C(=O)C1=CC=CC=C1 OGEMCJNRDGZFQF-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- VHRYZQNGTZXDNX-UHFFFAOYSA-N methacryloyl chloride Chemical compound CC(=C)C(Cl)=O VHRYZQNGTZXDNX-UHFFFAOYSA-N 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- HMZGPNHSPWNGEP-UHFFFAOYSA-N octadecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C(C)=C HMZGPNHSPWNGEP-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- SMYREFDDLSTNKQ-UHFFFAOYSA-N oxocan-2-ol Chemical compound OC1CCCCCCO1 SMYREFDDLSTNKQ-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- DFOXKPDFWGNLJU-UHFFFAOYSA-N pinacolyl alcohol Chemical compound CC(O)C(C)(C)C DFOXKPDFWGNLJU-UHFFFAOYSA-N 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- PQRHBEQNPCVBSM-UHFFFAOYSA-M potassium;2-carboxybenzoate;hydrochloride Chemical compound Cl.[K+].OC(=O)C1=CC=CC=C1C([O-])=O PQRHBEQNPCVBSM-UHFFFAOYSA-M 0.000 description 1
- KVMLCRQYXDYXDX-UHFFFAOYSA-M potassium;chloride;hydrochloride Chemical compound Cl.[Cl-].[K+] KVMLCRQYXDYXDX-UHFFFAOYSA-M 0.000 description 1
- AFDCXHSYKIVOOQ-UHFFFAOYSA-K potassium;disodium;phosphate Chemical compound [Na+].[Na+].[K+].[O-]P([O-])([O-])=O AFDCXHSYKIVOOQ-UHFFFAOYSA-K 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- NARVIWMVBMUEOG-UHFFFAOYSA-N prop-1-en-2-ol Chemical group CC(O)=C NARVIWMVBMUEOG-UHFFFAOYSA-N 0.000 description 1
- ARJOQCYCJMAIFR-UHFFFAOYSA-N prop-2-enoyl prop-2-enoate Chemical compound C=CC(=O)OC(=O)C=C ARJOQCYCJMAIFR-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical group CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 230000005068 transpiration Effects 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- WCTAGTRAWPDFQO-UHFFFAOYSA-K trisodium;hydrogen carbonate;carbonate Chemical compound [Na+].[Na+].[Na+].OC([O-])=O.[O-]C([O-])=O WCTAGTRAWPDFQO-UHFFFAOYSA-K 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、皮膚外用剤、更に詳細には、皮膚バリアー機能向上作用に優れ、且つ使用感に優れる皮膚外用剤に関する。 The present invention relates to an external preparation for skin, and more particularly, to an external preparation for skin having excellent skin barrier function improving action and excellent usability.
ヒトの角層の主な役割は、皮膚内部からの水分の蒸散を抑制し、皮膚内部に水分を保持し、潤いを皮膚に与える、外部から、皮膚内部への刺激物の侵入を妨げ、皮膚内部を外部刺激から保護するなどの、いわゆる皮膚バリアーの働きをすることである。しかしながら、近年、種々の化学物質との接触の機会が増加しており、それら外的要因やストレス等の内的要因により、角層のバリアー機能が低下しているケースが多くなっている。 The main role of the human stratum corneum is to suppress the transpiration of moisture from the inside of the skin, to retain moisture inside the skin, to moisturize the skin, to prevent the entry of irritants into the skin from the outside, and to the skin It acts as a so-called skin barrier, such as protecting the inside from external stimuli. However, in recent years, the chance of contact with various chemical substances has increased, and the barrier function of the stratum corneum has decreased due to such external factors and internal factors such as stress.
このような状況下、化粧品、特に、スキンケア品には、低下した角層のバリアー機能を向上させる作用が求められており、そのような手段として、水溶性高分子を化粧料中に配合し、肌上に被膜を形成させ、この被膜により、低下した角層のバリアー機能を補完しようとする試みがなされている。このようなポリマーとしては、肌との親和性に優れる側鎖構造を有するポリマーが好ましく、側鎖に糖構造を有するポリマーが多用されている。(例えば、特許文献1,特許文献2,特許文献3,特許文献4,特許文献5参照) Under such circumstances, cosmetics, particularly skin care products, are required to have an effect of improving the barrier function of the reduced stratum corneum. As such means, a water-soluble polymer is blended in the cosmetic, Attempts have been made to form a film on the skin and to supplement the reduced barrier function of the stratum corneum with this film. As such a polymer, a polymer having a side chain structure excellent in affinity with the skin is preferable, and a polymer having a sugar structure in the side chain is frequently used. (For example, see Patent Document 1, Patent Document 2, Patent Document 3, Patent Document 4, and Patent Document 5)
しかしながら、これらのポリマーを配合した化粧料は、角層のバリアーを向上させる作用には優れるものの、使用中に水溶性高分子特有のきしみを感じる、被膜の柔軟性が低いために、肌が突っ張るような使用後感がある、等の使用感に課題を有する場合があった。
すなわち、使用感が良好で、皮膚バリアー機能の向上作用に優れる皮膚外用剤の開発が望まれていた。
However, cosmetics containing these polymers are excellent in the action of improving the barrier of the stratum corneum, but feel the squeaks peculiar to water-soluble polymers during use, and the skin is stretched due to the low flexibility of the film. There are cases where there is a problem in the feeling of use such as the feeling after use.
That is, it has been desired to develop an external preparation for skin that has a good feeling of use and is excellent in improving the skin barrier function.
一方、糖側鎖を有するアクリル系モノマーと特定の分岐構造のアルキル基を有するアクリル系モノマーからなるコポリマーが肌上で摩擦係数が低く、柔軟性に優れる被膜を形成すること、さらには該ポリマーを含有する皮膚外用剤が、使用中のきしみ、使用後のつっぱり感のない、優れた使用感と優れた皮膚バリアー向上作用を併せ持つことは知られていなかった。 On the other hand, a copolymer comprising an acrylic monomer having a sugar side chain and an acrylic monomer having an alkyl group having a specific branched structure forms a film having a low friction coefficient on the skin and excellent flexibility, and further It has not been known that the skin external preparation contained has both excellent use feeling and excellent skin barrier improving action without creaking during use and feeling of tension after use.
本発明の目的は、皮膚バリアー向上作用及び使用感に優れる皮膚外用剤を提供することにある。 The objective of this invention is providing the skin external preparation excellent in the skin barrier improvement effect | action and a usability | use_condition.
このような状況を鑑み、本発明者等は、皮膚バリアー向上作用及び使用感に優れる皮膚外用剤を求めて鋭意研究した結果、糖側鎖を有するアクリル系モノマーから誘導される構成単位、疎水性の、特定の分岐構造を有するアクリル系モノマーから誘導される構成単位を必須構成単位として含有するコポリマーを含有する皮膚外用剤が課題を解決することを見出し、本発明に至った。すなわち、本発明は以下の通りである。
(1)下記一般式(I)で表されるモノマーから誘導される一種または二種以上の構成単位と、一般式(II)で表される疎水性モノマーから誘導される一種または二種以上の構成単位を必須構成単位として有するコポリマーを含有することを特徴とする皮膚外用剤。
一般式(I)
(一般式(I)中R1は水素原子またはメチル基を、G−O−は還元糖の1位の水酸基より水素を除いた基を表す。nは2又は3を、mは1〜5の整数を表す。)
一般式(II)
(一般式(II)中R2は水素原子または炭素数1〜3のアルキル基を表し、R3は環構造を含まない、炭素数13〜30の分岐状炭化水素基、または、環構造を含まない、2つ以上の分岐を有する炭素数6〜12の炭化水素基を表す。)
(2)さらに、コポリマーが、重合性カルボン酸及びその塩、下記一般式(III)で表される親水性モノマーからなる群より選択される一種又は二種以上のモノマーから誘導される構成単位を含有することを特徴とする(1)記載の皮膚外用剤。
一般式(III)
(一般式(III)中R4は水素原子または炭素数1〜3のアルキル基を表し、R5は水酸基を有していてもよい炭素数2〜4のアルキレン基を表し、R6は水素原子、炭素数6〜10の芳香族炭化水素基、炭素数1〜14の脂肪族炭化水素基又は炭素数1〜12のアシル基を表す。pは4〜40の整数を表す。)
(3)一般式(III)で表される親水性モノマーが、下記一般式(IV)で表される親水性モノマーであることを特徴とする(2)に記載の皮膚外用剤。
一般式(IV)
(一般式(IV)中R7は水素原子または炭素数1〜3のアルキル基を表し、R8は水素原子、炭素数6〜10の芳香族炭化水素基、炭素数1〜14の脂肪族炭化水素基又は炭素数1〜12のアシル基を表す。qは4〜40の整数を表す。)
(4)重合性カルボン酸がアクリル酸及び/またはメタクリル酸であることを特徴とする(2)又は(3)に記載の皮膚外用剤。
(5)コポリマーを皮膚外用剤全量の0.5〜25質量%含有することを特徴とする(1)〜(4)の何れかに記載の皮膚外用剤。
(6)化粧料であることを特徴とする(1)〜(5)の何れかに記載の皮膚外用剤。
In view of such a situation, the present inventors have intensively studied for a skin external preparation excellent in skin barrier improving action and usability, and as a result, a structural unit derived from an acrylic monomer having a sugar side chain, hydrophobicity The topical skin preparation containing a copolymer containing a structural unit derived from an acrylic monomer having a specific branched structure as an essential structural unit has been found to solve the problem, and the present invention has been achieved. That is, the present invention is as follows.
(1) One or more structural units derived from the monomer represented by the following general formula (I) and one or more structural units derived from the hydrophobic monomer represented by the general formula (II) A skin external preparation comprising a copolymer having a structural unit as an essential structural unit.
Formula (I)
(In general formula (I), R 1 represents a hydrogen atom or a methyl group, G—O— represents a group in which hydrogen is removed from the hydroxyl group at the 1-position of the reducing sugar, n is 2 or 3, and m is 1 to 5). Represents an integer.)
Formula (II)
(In General Formula (II), R 2 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R 3 represents a branched hydrocarbon group having 13 to 30 carbon atoms or a ring structure that does not include a ring structure. (A hydrocarbon group having 6 to 12 carbon atoms having two or more branches not included)
(2) Further, the copolymer is a structural unit derived from one or more monomers selected from the group consisting of a polymerizable carboxylic acid and a salt thereof, and a hydrophilic monomer represented by the following general formula (III). The skin external preparation as described in (1) characterized by containing.
Formula (III)
(In general formula (III), R 4 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R 5 represents an alkylene group having 2 to 4 carbon atoms which may have a hydroxyl group, and R 6 represents hydrogen. An atom, an aromatic hydrocarbon group having 6 to 10 carbon atoms, an aliphatic hydrocarbon group having 1 to 14 carbon atoms, or an acyl group having 1 to 12 carbon atoms, p represents an integer of 4 to 40.)
(3) The external preparation for skin according to (2), wherein the hydrophilic monomer represented by the general formula (III) is a hydrophilic monomer represented by the following general formula (IV).
Formula (IV)
(In general formula (IV), R 7 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R 8 represents a hydrogen atom, an aromatic hydrocarbon group having 6 to 10 carbon atoms, or an aliphatic group having 1 to 14 carbon atoms. And represents a hydrocarbon group or an acyl group having 1 to 12 carbon atoms, q represents an integer of 4 to 40.)
(4) The external preparation for skin according to (2) or (3), wherein the polymerizable carboxylic acid is acrylic acid and / or methacrylic acid.
(5) The skin external preparation according to any one of (1) to (4), wherein the copolymer is contained in an amount of 0.5 to 25% by mass based on the total amount of the external preparation for skin.
(6) The external preparation for skin according to any one of (1) to (5), which is a cosmetic.
本発明によれば、皮膚バリアー向上作用及び使用感に優れる皮膚外用剤を提供することができる。
ADVANTAGE OF THE INVENTION According to this invention, the skin external preparation excellent in the skin barrier improvement effect | action and usability | use_condition can be provided.
以下、本発明を詳細に説明する。
<1> 本発明の皮膚外用剤の必須成分であるコポリマーを構成する糖残基を有するモノマーから誘導される構成単位
本発明の皮膚外用剤の必須成分でコポリマー(以下、単に本発明のコポリマーと呼ぶ場合がある)は下記一般式(I)で表される糖残基を有するモノマーから誘導される構成単位を必須構成単位として含有する。なお、本発明において、「モノマーから誘導される構成単位」とは、対応するモノマーが有する炭素−炭素不飽和結合が重合反応によって開裂して形成される構成単位を言う。
一般式(I)
(一般式(I)中R1は水素原子またはメチル基を、G−O−は還元糖の1位の水酸基より水素を除いた基を表す。nは2又は3を、mは1〜5の整数を表す。)
Hereinafter, the present invention will be described in detail.
<1> A structural unit derived from a monomer having a sugar residue constituting a copolymer which is an essential component of the external preparation of the present invention. An essential component of the external preparation of the present invention (hereinafter simply referred to as a copolymer of the present invention). May contain a structural unit derived from a monomer having a sugar residue represented by the following general formula (I) as an essential structural unit. In the present invention, the “structural unit derived from a monomer” refers to a structural unit formed by cleavage of a carbon-carbon unsaturated bond of a corresponding monomer by a polymerization reaction.
Formula (I)
(In general formula (I), R 1 represents a hydrogen atom or a methyl group, G—O— represents a group in which hydrogen is removed from the hydroxyl group at the 1-position of the reducing sugar, n is 2 or 3, and m is 1 to 5). Represents an integer.)
一般式(I)のモノマーにおいて、G−O−で表される還元糖の1位の水酸基より水素を除いた基の還元糖としては、具体的には、グルコース、マンノース、ガラクトース、アラビノース、キシロース、リボースなどの単糖、マルトース、ラクトース、セロビオース等の2糖、マルトトリオース等の3糖、マルトオリゴ糖等のオリゴ糖からなる群から選択される一種または二種以上が例示されるが、中でも、グルコース、ガラクトース、アラビノース、キシロース、リボース、マルトース、ラクトースセロビオースからなる群から選択される一種または二種以上が好ましく、グルコースが特に好ましい。また、一般式(I)で表されるモノマーとしては、グルコシルオキシエチルメタクリレート(以下GEMAと省略する。)またはグルコシルオキシエチルアクリレート(以下GEAと省略する。)が好ましい。 In the monomer of the general formula (I), as the reducing sugar of the group obtained by removing hydrogen from the hydroxyl group at the 1-position of the reducing sugar represented by G-O-, specifically, glucose, mannose, galactose, arabinose, xylose And one or more selected from the group consisting of monosaccharides such as ribose, disaccharides such as maltose, lactose and cellobiose, trisaccharides such as maltotriose, and oligosaccharides such as maltooligosaccharide, 1 type, or 2 or more types selected from the group consisting of glucose, galactose, arabinose, xylose, ribose, maltose, and lactose cellobiose are preferable, and glucose is particularly preferable. The monomer represented by the general formula (I) is preferably glucosyloxyethyl methacrylate (hereinafter abbreviated as GEMA) or glucosyloxyethyl acrylate (hereinafter abbreviated as GEA).
本発明のコポリマーにおける、一般式(I)で表されるモノマーから誘導される構成単位の全構成単位に占める割合は、好ましくは5〜90質量%、より好ましくは、10〜85質量%である。下限以下では、得られるコポリマーを含有する皮膚外用剤の形成する被膜の肌との親和性が低い場合があり好ましくない。また、上限以上では、得られるコポリマーを含有する皮膚外用剤が使用時にきしみ、つっぱり感を生じる場合があり好ましくない。 The proportion of the structural unit derived from the monomer represented by formula (I) in the copolymer of the present invention in the total structural unit is preferably 5 to 90% by mass, more preferably 10 to 85% by mass. . Below the lower limit, the film formed by the external preparation for skin containing the copolymer may have a low affinity with the skin, which is not preferable. On the other hand, if the amount is not less than the upper limit, the external preparation for skin containing the obtained copolymer may be squeezed at the time of use and may cause a feeling of tension.
<2> 本発明の皮膚外用剤の必須成分であるコポリマーを構成する疎水性モノマーから誘導される構成単位。
本発明の皮膚外用剤の必須成分であるコポリマーは下記一般式(II)で表される疎水性モノマーから誘導される構成単位(以下、単に、「構成単位IIと呼ぶこともある)の一種又は二種以上を必須構成単位として含有する。
一般式(II)
(一般式(II)中R2は水素原子または炭素数1〜3のアルキル基を表し、R3は、環構造を含まない、炭素数13〜30の分岐状炭化水素基、または、環構造を含まない、2つ以上の分岐を有する炭素数6〜12の炭化水素基を表す。)
<2> A structural unit derived from a hydrophobic monomer constituting a copolymer which is an essential component of the external preparation for skin of the present invention.
The copolymer that is an essential component of the external preparation for skin of the present invention is a structural unit derived from a hydrophobic monomer represented by the following general formula (II) (hereinafter, simply referred to as “structural unit II”) or Contains two or more as essential constituent units.
Formula (II)
(In General Formula (II), R 2 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 3 represents a branched hydrocarbon group having 13 to 30 carbon atoms that does not include a ring structure, or a ring structure. Represents a C6-C12 hydrocarbon group having two or more branches.
ここで、R2で表されるアルキル基としては、メチル基、エチル基、プロピル基、イソプロピル基、シクロプロピル基等が例示できる。本発明において、R2は水素原子又はメチル基であることが好ましい。 Here, examples of the alkyl group represented by R 2 include a methyl group, an ethyl group, a propyl group, an isopropyl group, and a cyclopropyl group. In the present invention, R 2 is preferably a hydrogen atom or a methyl group.
また、R3で表される、環構造を含まない、炭素数13〜30の分岐状炭化水素基としては、1−メチルドデカニル基、11−メチルドデカニル基、3−エチルウンデカニル基、3−エチル−4,5,6−トリメチルオクチル基、1−メチルトリデカニル基、1−ヘキシルオクチル基、2−ブチルデカニル基、2−ヘキシルオクチル基、4−エチル−1−イソブチルオクチル基、1−メチルペンタデカニル基、2−ヘキシルデカニル基、2−オクチルデカニル基、2−ヘキシルドデカニル基、16−メチルヘプタデカニル基、9−メチルヘプタデカニル基、7−メチル−2−(3−メチルヘキシル)デカニル基、3,7,11,15−テトラ−メチルヘキサデカニル基、2−オクチルドデカニル基、2−デシルテトラデカニル基、2−ドデシルヘキサデカニル基等を例示することができる。 Examples of the branched hydrocarbon group having 13 to 30 carbon atoms that does not include a ring structure represented by R 3 include 1-methyldodecanyl group, 11-methyldodecanyl group, and 3-ethylundecanyl group. 3-ethyl-4,5,6-trimethyloctyl group, 1-methyltridecanyl group, 1-hexyloctyl group, 2-butyldecanyl group, 2-hexyloctyl group, 4-ethyl-1-isobutyloctyl group, 1-methylpentadecanyl group, 2-hexyldecanyl group, 2-octyldecanyl group, 2-hexyldecanyl group, 16-methylheptadecanyl group, 9-methylheptadecanyl group, 7-methyl-2 -(3-methylhexyl) decanyl group, 3,7,11,15-tetra-methylhexadecanyl group, 2-octyldodecanyl group, 2-decyltetradecanyl group, 2-dodecylhexyl It can be exemplified decanyl group.
また、R3で表される、環構造を含まない、2つ以上の分岐を有する炭素数6〜12の炭化水素基としては2,2−ジメチルブチル基、2,3−ジメチルブチル基、3,3−ジメチルブチル基、1,3−ジメチルブチル基、1,2,2−トリメチルプロピル基、1,1−ジメチルペンタニル基、1−イソプロピルブチル基、1−イソプロピル−2−メチルプロピル基、1,1−ジエチルプロピル基、1−エチル−1−イソプロピルプロピル基、2−エチル−4−メチルペンチル基、1−プロピル−2,2−ジメチルプロピル基、1,1、2−トリメチル−ペンチル基、1−イソプロピル−3−メチルブチル基、1,2−ジメチル−1−エチルブチル基、1,3−ジメチル−1−エチルブチル基、1−エチル−1−イソプロピル−プロピル基、1,1−ジメチルヘキシル基、1−メチル−1−エチルペンチル基、1−メチル−1−プロピルブチル基、1,4―ジメチルヘキシル基、1−エチル−3―メチルペンチル基、1,5―ジメチルヘキシル基、1−エチル−6−メチルヘプチル基、1,1,3,3−テトラメチルブチル基、1,2−ジメチル−1−イソプロピルプロピル基、3−メチル−1−(2,2−ジメチルエチル)ブチル基、1−イソプロピルヘキシル基(C9)、3.5.5−トリメチルヘキシル基、2−イソプロピル−5−メチルヘキシル基、1,5−ジメチル−1−エチルヘキシル基、3,7−ジメチルオクチル基、2,4,5−トリメチルヘプチル基、2,4,6−トリメチルヘプチル基、3,5−ジメチル−1−(2,2−ジメチルエチル)ヘキシル等を例示することができる。 Moreover, as a C6-C12 hydrocarbon group which does not contain the ring structure represented by R 3 and has two or more branches, 2,2-dimethylbutyl group, 2,3-dimethylbutyl group, 3 , 3-dimethylbutyl group, 1,3-dimethylbutyl group, 1,2,2-trimethylpropyl group, 1,1-dimethylpentanyl group, 1-isopropylbutyl group, 1-isopropyl-2-methylpropyl group, 1,1-diethylpropyl group, 1-ethyl-1-isopropylpropyl group, 2-ethyl-4-methylpentyl group, 1-propyl-2,2-dimethylpropyl group, 1,1,2-trimethyl-pentyl group 1-isopropyl-3-methylbutyl group, 1,2-dimethyl-1-ethylbutyl group, 1,3-dimethyl-1-ethylbutyl group, 1-ethyl-1-isopropyl-propyl group, 1,1-dimethylhexyl group, 1-methyl-1-ethylpentyl group, 1-methyl-1-propylbutyl group, 1,4-dimethylhexyl group, 1-ethyl-3-methylpentyl group, 1,5- Dimethylhexyl group, 1-ethyl-6-methylheptyl group, 1,1,3,3-tetramethylbutyl group, 1,2-dimethyl-1-isopropylpropyl group, 3-methyl-1- (2,2- Dimethylethyl) butyl group, 1-isopropylhexyl group (C9), 3.5.5-trimethylhexyl group, 2-isopropyl-5-methylhexyl group, 1,5-dimethyl-1-ethylhexyl group, 3,7- Examples include dimethyloctyl group, 2,4,5-trimethylheptyl group, 2,4,6-trimethylheptyl group, 3,5-dimethyl-1- (2,2-dimethylethyl) hexyl Rukoto can.
本発明のコポリマーに含まれる構成単位IIは1種のみでもよいが、上記一般式(II)を満たすものであれば2種以上の構成単位IIを組み合わせて含有していてもよい。本発明のコポリマーにおける、構成単位IIの全構成単位に占める割合は、好ましくは1〜40質量%、より好ましくは、5〜35質量%である。下限以下では、得られるコポリマーを含有する皮膚外用剤が使用時にきしみ、つっぱり感を生じる場合があり好ましくない。また、上限以上では得られるコポリマーの皮膚外用剤成分への、特に水への溶解性が低下する場合があり、好ましくない。 The constitutional unit II contained in the copolymer of the present invention may be only one type, but may contain two or more constitutional units II in combination as long as the general formula (II) is satisfied. The proportion of the structural unit II in all the structural units in the copolymer of the present invention is preferably 1 to 40% by mass, more preferably 5 to 35% by mass. Below the lower limit, the resulting external preparation for skin containing the copolymer may be squeezed at the time of use and may cause a tight feeling, which is not preferable. On the other hand, if it exceeds the upper limit, the solubility of the resulting copolymer in the external preparation for skin, particularly in water, may be lowered, which is not preferable.
一般式(II)で表されるモノマーは該当するアルコールと(メタ)アクリル酸、(メタ)アクリル酸無水物又は(メタ)アクリル酸クロライドとのエステル化反応により、容易に合成することが可能である。以下、一般式(II)で表される疎水性モノマーの製造例を示す。 The monomer represented by the general formula (II) can be easily synthesized by an esterification reaction between the corresponding alcohol and (meth) acrylic acid, (meth) acrylic anhydride or (meth) acrylic acid chloride. is there. Hereinafter, production examples of the hydrophobic monomer represented by the general formula (II) will be shown.
<製造例1>
攪拌装置を備えた反応容器中で、3,3−ジメチル−2−ブタノール(東京化成工業(株)製)20.4g(0.2モル)、トリエチルアミン50.0gをテトラヒドロフラン500mlに溶解した。得られた溶液を氷冷、攪拌しながら、酸クロライドとして、アクリル酸クロライド(東京化成工業(株)製)18.1gをテトラヒドロフラン100mlに溶解してなる溶液を2時間かけて滴下した。滴下終了後、生成した白色沈殿を濾過し、濾液からロータリーエバポレーターを用いてテトラヒドロフラン及びトリエチルアミンを除去して生成物を得た。NMR測定により、得られた化合物が、一般式(V)で表される、1、2,2−トリメチルプロピルアクリレートであることが確認された。
一般式(V)
<Production Example 1>
In a reaction vessel equipped with a stirrer, 20.4 g (0.2 mol) of 3,3-dimethyl-2-butanol (manufactured by Tokyo Chemical Industry Co., Ltd.) and 50.0 g of triethylamine were dissolved in 500 ml of tetrahydrofuran. While the resulting solution was ice-cooled and stirred, a solution prepared by dissolving 18.1 g of acrylic acid chloride (manufactured by Tokyo Chemical Industry Co., Ltd.) in 100 ml of tetrahydrofuran was added dropwise over 2 hours as an acid chloride. After completion of the dropwise addition, the produced white precipitate was filtered, and tetrahydrofuran and triethylamine were removed from the filtrate using a rotary evaporator to obtain a product. NMR measurement confirmed that the obtained compound was 1,2,2-trimethylpropyl acrylate represented by the general formula (V).
General formula (V)
<製造例2〜6>
製造例1におけるアルコール及び酸クロライドを表1に示すように変更した以外は、上記製造例1と同様の操作を行って、一般式(II)で表される疎水性モノマーを調製した。得られた疎水性モノマーを表1及び一般式(VI)〜(X)に示す。
<Production Examples 2-6>
A hydrophobic monomer represented by the general formula (II) was prepared in the same manner as in Production Example 1 except that the alcohol and acid chloride in Production Example 1 were changed as shown in Table 1. The obtained hydrophobic monomers are shown in Table 1 and general formulas (VI) to (X).
* 2)東京化成工業(株)製
* 3)「ノナノール」協和発酵ケミカル(株)製
* 4)東京化成工業(株)製
* 5)「リソノール16SP」高級アルコール工業(株)製
* 6)「ファインオキソコール(登録商標) 180」日産化学工業(株)製
製造例2の化合物
一般式(VI)
Compound of Preparation Example 2 (VI)
製造例3の化合物
一般式(VII)
Compound of Production Example 3 (VII)
製造例4の化合物
一般式(VIII)
Compound of Production Example 4 (VIII)
製造例5の化合物
一般式(IX)
Compound of Production Example 5 (IX)
製造例6の化合物
一般式(X)
Compound of Production Example 6 (X)
<3> 本発明のコポリマーを構成する親水性モノマーから誘導される構成単位。
本発明のコポリマーは前述の一般式(I)で表されるモノマーから誘導される構成単位及び一般式(II)で表されるモノマーから誘導される構成単位を必須構成単位として含有するが、必要に応じて他の構成単位を含有しても良い。このような構成単位としては、コポリマーの溶解性、特に水への溶解性を向上させることから、重合性カルボン酸、その塩又は下記一般式(III)で表されるモノマーからなる群から選択される親水性モノマーから誘導される構成単位の一種または二種以上が好ましい。(以下、一般式(III)で表されるモノマーからなる群から選択される親水性モノマー誘導される構成単位を単に、構成単位IIIと呼ぶことがある。)
一般式(III)
(一般式(III)中R4は水素原子または炭素数1〜3のアルキル基を表し、R5は水酸基を有していてもよい炭素数2〜4のアルキレン基を表し、R6は水素原子、炭素数6〜10の芳香族炭化水素基、炭素数1〜14の脂肪族炭化水素基又は炭素数1〜12のアシル基を表す。pは4〜40の整数を表す。)
<3> A structural unit derived from a hydrophilic monomer constituting the copolymer of the present invention.
The copolymer of the present invention contains a structural unit derived from the monomer represented by the general formula (I) and a structural unit derived from the monomer represented by the general formula (II) as essential structural units. Depending on the above, other structural units may be contained. Such a structural unit is selected from the group consisting of a polymerizable carboxylic acid, a salt thereof, or a monomer represented by the following general formula (III) in order to improve the solubility of the copolymer, particularly the solubility in water. One or more structural units derived from a hydrophilic monomer are preferred. (Hereinafter, the structural unit derived from the hydrophilic monomer selected from the group consisting of the monomer represented by the general formula (III) may be simply referred to as the structural unit III.)
Formula (III)
(In general formula (III), R 4 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R 5 represents an alkylene group having 2 to 4 carbon atoms which may have a hydroxyl group, and R 6 represents hydrogen. An atom, an aromatic hydrocarbon group having 6 to 10 carbon atoms, an aliphatic hydrocarbon group having 1 to 14 carbon atoms, or an acyl group having 1 to 12 carbon atoms, p represents an integer of 4 to 40.)
重合性カルボン酸又はその塩としては、具体的には、アクリル酸、メタクリル酸、クロトン酸、イタコン酸、フマル酸及びそのナトリウム塩、カリウム塩、アンモニウム塩、アミン塩等が例示できる。これらの中では、重合性が高いことから、アクリル酸、メタクリル酸及びその塩が特に好ましい。本発明のコポリマーに重合性のカルボン酸の塩から誘導される構成単位を導入する場合は重合性カルボン酸を予め塩となし、重合反応を行っても良いし、重合反応により、重合性カルボン酸から誘導される構成単位をコポリマーに誘導した後、塩基により中和して塩となしてもよい。 Specific examples of the polymerizable carboxylic acid or its salt include acrylic acid, methacrylic acid, crotonic acid, itaconic acid, fumaric acid and its sodium salt, potassium salt, ammonium salt, amine salt and the like. Among these, acrylic acid, methacrylic acid and salts thereof are particularly preferable because of high polymerizability. When a structural unit derived from a salt of a polymerizable carboxylic acid is introduced into the copolymer of the present invention, the polymerizable carboxylic acid may be converted into a salt in advance, and a polymerization reaction may be performed. The structural unit derived from may be derived into a copolymer and then neutralized with a base to form a salt.
一般式(III)においてR4で表されるアルキル基としては、メチル基、エチル基、プロピル基、1−メチルエチル基、シクロプロピル基が例示できる。本発明において、R4は水素原子又はメチル基であることが好ましい。 Examples of the alkyl group represented by R 4 in the general formula (III) include a methyl group, an ethyl group, a propyl group, a 1-methylethyl group, and a cyclopropyl group. In the present invention, R 4 is preferably a hydrogen atom or a methyl group.
また、R5で表されるアルキレン基としては、エチレン基、プロピレン基、イソプロピレン基、2−ヒドロキシプロピレン基、1−ヒドロキシ−2−メチルエチレン基、2−ヒドロキシ−1−メチルエチレン基などが例示できるが、これらのうち、好ましくはエチレン基又はプロピレン基であり、より好ましくはエチレン基である。 Examples of the alkylene group represented by R 5 include an ethylene group, a propylene group, an isopropylene group, a 2-hydroxypropylene group, a 1-hydroxy-2-methylethylene group, and a 2-hydroxy-1-methylethylene group. Of these, ethylene group or propylene group is preferable, and ethylene group is more preferable.
また、R6で表される基のうち、炭素数6〜10の芳香族基としては、フェニル基、ベンジル基、メチルフェニル基、エチルフェニル基等が例示でき;炭素数1〜14の脂肪族炭化水素基としては、メチル基、エチル基、ブチル基、ターシャリーブチル基、ヘキシル基、シクロへキシル基、オクチル基、2−エチルへキシル基、ラウリル基などが好適に例示でき;炭素数1〜12のアシル基としては、フォルミル基、アセチル基、プロピオニル基、ブチリル基、イソブチリル基、バレリル基、ラウロイル基などが好適に例示できる。これらのうち、R5で表される基として好ましくは炭素数1〜14の脂肪族炭化水素基であり、より好ましくは炭素数1〜12のアルキル基である。 Among the groups represented by R 6 , examples of the aromatic group having 6 to 10 carbon atoms include a phenyl group, a benzyl group, a methylphenyl group, and an ethylphenyl group; an aliphatic group having 1 to 14 carbon atoms Preferred examples of the hydrocarbon group include a methyl group, an ethyl group, a butyl group, a tertiary butyl group, a hexyl group, a cyclohexyl group, an octyl group, a 2-ethylhexyl group, and a lauryl group; Preferable examples of the ˜12 acyl group include a formyl group, an acetyl group, a propionyl group, a butyryl group, an isobutyryl group, a valeryl group, and a lauroyl group. Among these, the group represented by R 5 is preferably an aliphatic hydrocarbon group having 1 to 14 carbon atoms, and more preferably an alkyl group having 1 to 12 carbon atoms.
さらに、一般式(III)におけるpは4〜40の数値範囲であることが重要である。本発明においてnが上記範囲である構成単位IIをコポリマーに導入することにより、皮膚外用剤の構成成分、特に水への溶解性を向上させることができる。pが4未満の場合は得られるコポリマーの皮膚外用剤の構成成分、特に水への溶解性を向上させることができない場合があり、好ましくない。反対に、pが40より大きすぎると皮膚外用剤の使用時のきしみが増大する場合があるので好ましくない。 Furthermore, it is important that p in the general formula (III) is in a numerical range of 4 to 40. In the present invention, by introducing the structural unit II in which n is in the above range into the copolymer, the solubility of the external preparation for skin, particularly water, can be improved. When p is less than 4, it may not be possible to improve the solubility of the obtained copolymer in the external preparation for skin, particularly water, which is not preferable. On the other hand, if p is more than 40, it is not preferable because squeeze during use of the external preparation for skin may increase.
上記一般式(III)で表されるモノマーのうち、R5がプロピレン基であるモノマーとして具体的には、ポリプロピレングリコール(6)モノアクリレート、ポリプロピレングリコール(9)モノアクリレート、ポリプロピレングリコール(13)モノアクリレート、ポリプロピレングリコール(9)モノメタクリレート、ポリプロピレングリコール(13)モノメタクリレート等が挙げられる。なお、括弧内の数字はpの値を表す。これらのポリマーの多くは市販品として入手可能である。これら市販品としては、具体的には、商品名「ブレンマー」AP−400、AP−550、AP−800、PP−500、PP−800(いずれも日本油脂(株)製)等が例示できる。なお、R5がエチレン基であるモノマーの具体例は後述する。 Among the monomers represented by the general formula (III), specific examples of the monomer in which R 5 is a propylene group include polypropylene glycol (6) monoacrylate, polypropylene glycol (9) monoacrylate, and polypropylene glycol (13) mono Examples thereof include acrylate, polypropylene glycol (9) monomethacrylate, polypropylene glycol (13) monomethacrylate and the like. The numbers in parentheses represent the value of p. Many of these polymers are commercially available. Specific examples of these commercially available products include “Blemmer” AP-400, AP-550, AP-800, PP-500, PP-800 (all manufactured by NOF Corporation) and the like. A specific example of the monomer in which R 5 is an ethylene group will be described later.
上記一般式(III)で表される親水性モノマーから誘導される構成単位の中でも特に好ましいものとして、下記一般式(IV)で表される親水性モノマーから誘導される構成単位が挙げられる。
一般式(IV)
(一般式(IV)中R7は水素原子または炭素数1〜3のアルキル基を表し、R8は水素原子、炭素数6〜10の芳香族炭化水素基、炭素数1〜14の脂肪族炭化水素基又は炭素数1〜12のアシル基を表す。qは4〜40の整数を表す。)
Among the structural units derived from the hydrophilic monomer represented by the general formula (III), structural units derived from the hydrophilic monomer represented by the following general formula (IV) are particularly preferable.
Formula (IV)
(In general formula (IV), R 7 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R 8 represents a hydrogen atom, an aromatic hydrocarbon group having 6 to 10 carbon atoms, or an aliphatic group having 1 to 14 carbon atoms. And represents a hydrocarbon group or an acyl group having 1 to 12 carbon atoms, q represents an integer of 4 to 40.)
このような一般式(IV)で表されるモノマーを具体的に例示すれば、ポリエチレングリコール(10)モノアクリレート、ポリエチレングリコール(8)モノメタクリレート、メトキシポリエチレングリコール(9)アクリレート、メトキシポリエチレングリコール(4)メタクリレート、メトキシポリエチレングリコール(8)メタクリレート、メトキシポリエチレングリコール(9)メタクリレート、メトキシポリエチレングリコール(23)メタクリレート、オレイロキシポリエチレングリコール(18)メタクリレート、ラウロキシポリエチレングリコール(4)アクリレート、ラウロキシポリエチレングリコール(18)アクリレート、ラウロキシポリエチレングリコール(4)メタクリレート、ラウロイロキシポリエチレングリコール(10)メタクリレート、ステアロキシポリエチレングリコール(4)メタクリレート、ステアロキシポリエチレングリコール(9)メタクリレート、ステアロキシポリエチレングリコール(30)メタクリレート、ノニルフェノキシポリエチレングリコール(30)モノアクリレート等が挙げられる。なお、カッコ内の数字はqの値を示す。 Specific examples of the monomer represented by the general formula (IV) include polyethylene glycol (10) monoacrylate, polyethylene glycol (8) monomethacrylate, methoxypolyethylene glycol (9) acrylate, methoxypolyethylene glycol (4 ) Methacrylate, methoxypolyethylene glycol (8) methacrylate, methoxypolyethylene glycol (9) methacrylate, methoxypolyethylene glycol (23) methacrylate, oleyloxypolyethylene glycol (18) methacrylate, lauroxypolyethylene glycol (4) acrylate, lauroxypolyethylene glycol ( 18) Acrylate, Lauroxy polyethylene glycol (4) Methacrylate, Lauroyloxy polyethylene glycol Call (10) methacrylate, stearoxypolyethylene polyethylene glycol (4) methacrylate, stearoxypolyethylene polyethylene glycol (9) methacrylate, stearoxypolyethylene polyethylene glycol (30) methacrylate, nonyl phenoxy polyethylene glycol (30) monoacrylate, and the like. The numbers in parentheses indicate the value of q.
なお、一般式(III)において述べたように、一般式(IV)においても同様に、膚外用剤の構成成分、特に水への溶解性を向上させ、かつ、皮膚外用剤の使用時のきしみを抑制するためにはqは4〜40の数値範囲であることが重要である。 As described in the general formula (III), in the general formula (IV) as well, the components of the external preparation for skin, particularly the solubility in water, are improved, and the squeaky when using the external preparation for skin is used. In order to suppress this, it is important that q is in the numerical range of 4 to 40.
これら上記の親水性モノマーは、対応するポリエチレングリコール、ポリエチレングリコールモノエーテル、ポリエチレングリコールモノエステルとアクリル酸、メタクリル酸のクロライド又は無水物とのエステル化反応により高収率で得ることができる。また、既に市販品も多数存在するので、かかる市販品を利用することも可能である。このような市販品としては、具体的に、商品名ブレンマー、AE−400、PE−350、AME−400、PME−200、PME−350、PME−400、PME−1000、ALE−200、ALE−800、PLE−200、PSE−200、PSE−400、PSE−1300、ANE−1300等(いずれも日本油脂(株)製)等が例示できる。 These hydrophilic monomers can be obtained in high yield by an esterification reaction between the corresponding polyethylene glycol, polyethylene glycol monoether, polyethylene glycol monoester and acrylic acid, methacrylic acid chloride or anhydride. Moreover, since there are already many commercial products, it is also possible to use such commercial products. Specific examples of such commercially available products include Blemmer, AE-400, PE-350, AME-400, PME-200, PME-350, PME-400, PME-1000, ALE-200, and ALE-. Examples include 800, PLE-200, PSE-200, PSE-400, PSE-1300, ANE-1300, etc. (all manufactured by NOF Corporation).
本発明のコポリマーに含まれる親水性のモノマーから誘導される構成単位は1種のみでもよいが、前述の条件を満たすものであれば2種以上の構成単位を組み合わせて含有していてもよい。 The structural unit derived from the hydrophilic monomer contained in the copolymer of the present invention may be only one type, but may contain two or more types of structural units in combination as long as the above-mentioned conditions are satisfied.
本発明のコポリマーに、親水性のモノマーから誘導される構成単位を含有させる場合は、その全構成単位に占める割合を50質量%以下にすることが好ましい。含有量が50質量%を超えると、得られるコポリマーを含有する皮膚外用剤が使用時にきしみ、つっぱり感を生じる場合があり好ましくない。 When the copolymer of the present invention contains a structural unit derived from a hydrophilic monomer, the proportion of the structural unit in all the structural units is preferably 50% by mass or less. If the content exceeds 50% by mass, the resulting external preparation for skin containing the copolymer may be squeezed at the time of use and may cause a feeling of tightness.
<4> 本発明のコポリマーに含まれうるその他の任意の構成単位
本発明のコポリマーは、上記の必須構成単位I、必須構成単位II及び親水性モノマーから誘導される構成単位以外に、通常共重合体で使用されるモノマーから誘導される構成単位を、発明の効果を損なわない範囲で任意の構成単位として有することができる。かかる任意の構成単位としては、アクリル酸アミド、メタクリル酸アミド、アクリル酸モノアルキルアミド、メタクリル酸モノアルキルアミド等の(メタ)アクリル酸アミド、(メタ)アクリル酸メチル、(メタ)アクリル酸エチル、(メタ)アクリル酸−n−ブチル、(メタ)アクリル酸イソブチル、(メタ)アクリル酸−tert−ブチル、(メタ)アクリル酸−n−オクチル、(メタ)アクリル酸−2エチルヘキシル、メタクリル酸−n−ドデシル、(メタ)アクリル酸ステアリル等の一般式(II)で表される疎水性モノマーに含まれない(メタ)アクリル酸アルキルエステル、(メタ)アクリル酸シクロヘキシル等の(メタ)アクリル酸の環状アルキルエステル;2−ヒドロキシエチル(メタ)アクリレート、2−ヒドロキシプロピル(メタ)アクリレート、4−ヒドロキシブチル(メタ)アクリレート等の(メタ)アクリル酸ヒドロキシアルキルエステル、(メタ)アクリル酸ベンジル等の(メタ)アクリル酸アリールエステル、(メタ)アクリル酸メトキシメチル、(メタ)アクリル酸メトキシエチル等の(メタ)アクリル酸アルコキシアルキルエステル、酢酸ビニル、ビニルピロリドン、スチレン、α−メチルスチレン;アクリロニトリル等のモノマーから誘導される構成単位が例示できる。これらのモノマーの殆どは市販品として入手可能である。
<4> Other Arbitrary Units that may be Included in the Copolymer of the Present Invention The copolymer of the present invention is a common copolymer other than the above-mentioned essential structural unit I, essential structural unit II, and structural units derived from hydrophilic monomers. A structural unit derived from a monomer used in the coalescence can be included as an arbitrary structural unit within a range not impairing the effects of the invention. Examples of such optional structural units include acrylic acid amide, methacrylic acid amide, acrylic acid monoalkylamide, (meth) acrylic acid amide such as methacrylic acid monoalkylamide, methyl (meth) acrylate, ethyl (meth) acrylate, (Meth) acrylic acid-n-butyl, (meth) acrylic acid isobutyl, (meth) acrylic acid-tert-butyl, (meth) acrylic acid-n-octyl, (meth) acrylic acid-2 ethylhexyl, methacrylic acid-n -Cyclic (meth) acrylic acid such as (meth) acrylic acid alkyl ester and (meth) acrylic acid cyclohexyl not included in the hydrophobic monomer represented by the general formula (II) such as dodecyl, stearyl (meth) acrylate, etc. Alkyl ester; 2-hydroxyethyl (meth) acrylate, 2-hydroxypropyl ( (Meth) acrylate, hydroxyalkyl ester of (meth) acrylic acid such as 4-hydroxybutyl (meth) acrylate, (meth) acrylic acid aryl ester such as benzyl (meth) acrylate, methoxymethyl (meth) acrylate, (meth) Examples include structural units derived from monomers such as (meth) acrylic acid alkoxyalkyl esters such as methoxyethyl acrylate, vinyl acetate, vinylpyrrolidone, styrene, α-methylstyrene; acrylonitrile. Most of these monomers are commercially available.
<5>本発明のコポリマー
本発明のコポリマーは、上記構成単位I、構成単位II、並びに、必要に応じて、親水性のモノマーから誘導される構成単位及び任意の構成単位を、その骨格中に含有する共重合体である。また、本発明のコポリマーは通常はその構成単位がランダムに結合したランダム共重合体であるが、ブロック共重合体又はグラフト共重合体であってもよい。
<5> Copolymer of the Present Invention The copolymer of the present invention comprises the structural unit I, the structural unit II, and, if necessary, a structural unit derived from a hydrophilic monomer and an arbitrary structural unit in its skeleton. It is a copolymer to contain. Further, the copolymer of the present invention is usually a random copolymer in which structural units are randomly bonded, but may be a block copolymer or a graft copolymer.
本発明のコポリマーの製造方法は特に限定されないが、例えば各構成単位を誘導するモノマーを溶媒中で混合し、アクリル系モノマーの重合で通常用いられる方法に従って重合反応を行う方法により得ることができる。 The method for producing the copolymer of the present invention is not particularly limited. For example, the copolymer can be obtained by a method in which monomers for deriving each structural unit are mixed in a solvent and a polymerization reaction is carried out according to a method usually used in the polymerization of acrylic monomers.
また、本発明のコポリマーは、皮膚外用剤へ含有させることが容易であることから、水溶性であることが好ましい。ここでいう水溶性コポリマーとは25℃において、コポリマーの20質量%水溶液の透過率が90%以上あるコポリマーと定義される。このようなポリマーを得るためには、上記重合方法の中でも前記モノマー混合物を、水溶液と25℃で水と任意の割合で混和する水性溶媒との混合溶媒中で、ラジカル重合する重合方法が特に好ましい。また、重合反応後の残存モノマーの量が少ないことから、水の替わりに緩衝溶液を用いる重合法がさらに好ましい。この方法で使用する緩衝作用を有する水溶液としては、通常使用される緩衝溶液であれば特に限定されないが、具体的には、塩化カリウム−塩酸溶液、フタル酸水素カリウム−塩酸溶液、リン酸二水素カリウム−リン酸水素二ナトリウム溶液、クエン酸水素カリウム−クエン酸溶液、炭酸ナトリウム−炭酸水素ナトリウム溶液等が例示できる。また、開始剤のイオンと緩衝溶液を形成するような塩類、酸或いは塩基類の水溶液を用い、開始剤を添加した時点で緩衝溶液をとなしてもよい。さらに、この方法で用いる25℃で水と任意の割合で混和する水性溶媒としては、具体的にはメチルアルコール、エチルアルコール、n−プロピルアルコール、イソプロピルアルコール等の炭素数1〜3のアルコール、アセトン、メチルエチルケトン等のケトン、エチレングリコール、ポリエチレングリコール、プロピレングリコール、1,3ブチレングリコール等のジオール、エチレングリコールモノメチルエーテル、エチレングリコールモノエチルエーテル等のエチレングリコールモノアルキルエーテル、テトラヒドロフラン等が例示できる。これらの水性溶媒の中では、重合反応が進行しやすいことから、メチルアルコール、エチルアルコール、n−プロピルアルコール、イソプロピルアルコール等の炭素数1〜3のアルコールが特に好ましい。 The copolymer of the present invention is preferably water-soluble because it can be easily contained in an external preparation for skin. The water-soluble copolymer here is defined as a copolymer having a transmittance of 90% or more of a 20% by mass aqueous solution of the copolymer at 25 ° C. In order to obtain such a polymer, among the above polymerization methods, a polymerization method in which the monomer mixture is radically polymerized in a mixed solvent of an aqueous solution and an aqueous solvent mixed with water at an arbitrary ratio at 25 ° C. is particularly preferable. . Moreover, since the amount of residual monomer after the polymerization reaction is small, a polymerization method using a buffer solution instead of water is more preferable. The aqueous solution having a buffering action used in this method is not particularly limited as long as it is a commonly used buffer solution. Specifically, potassium chloride-hydrochloric acid solution, potassium hydrogen phthalate-hydrochloric acid solution, dihydrogen phosphate Examples thereof include potassium-disodium hydrogen phosphate solution, potassium hydrogen citrate-citric acid solution, and sodium carbonate-sodium hydrogen carbonate solution. Alternatively, an aqueous solution of salts, acids, or bases that forms a buffer solution with the ions of the initiator may be used to form a buffer solution when the initiator is added. Furthermore, as an aqueous solvent mixed with water at an arbitrary ratio at 25 ° C. used in this method, specifically, alcohols having 1 to 3 carbon atoms such as methyl alcohol, ethyl alcohol, n-propyl alcohol and isopropyl alcohol, acetone Examples thereof include ketones such as methyl ethyl ketone, diols such as ethylene glycol, polyethylene glycol, propylene glycol and 1,3 butylene glycol, ethylene glycol monoalkyl ethers such as ethylene glycol monomethyl ether and ethylene glycol monoethyl ether, and tetrahydrofuran. Among these aqueous solvents, alcohols having 1 to 3 carbon atoms such as methyl alcohol, ethyl alcohol, n-propyl alcohol, and isopropyl alcohol are particularly preferable because the polymerization reaction easily proceeds.
以下、本発明のコポリマー、比較例のコポリマーの製造例を示す。
<製造例7>
窒素導入管、冷却器及び攪拌装置を備えたフラスコに、GEMA96.0g、製造例5の疎水性モノマー24.0g、イソプロピルアルコール300ml、水300mlを採り攪拌混合した。攪拌を続けながら、1時間窒素ガス置換を行った。これに過硫酸アンモニウム2.0gを水20mlに溶解した溶液を加え、更に攪拌を続けながら、65℃で16時間反応を行った。反応終了後、水酸化ナトリウム水溶液を用いてpHを7.0に調整し、ロータリーエバポレーターでイソプロピルアルコールを除去し、本発明のコポリマー1の水溶液を得た。
Hereinafter, production examples of the copolymer of the present invention and the copolymer of the comparative example will be shown.
<Production Example 7>
In a flask equipped with a nitrogen introduction tube, a condenser and a stirring device, 96.0 g of GEMA, 24.0 g of the hydrophobic monomer of Production Example 5, 300 ml of isopropyl alcohol, and 300 ml of water were taken and mixed. While stirring was continued, nitrogen gas substitution was performed for 1 hour. A solution prepared by dissolving 2.0 g of ammonium persulfate in 20 ml of water was added thereto, and the reaction was continued at 65 ° C. for 16 hours while continuing stirring. After completion of the reaction, the pH was adjusted to 7.0 using an aqueous sodium hydroxide solution, and isopropyl alcohol was removed using a rotary evaporator to obtain an aqueous solution of copolymer 1 of the present invention.
<製造例8>
窒素導入管、冷却器及び攪拌装置を備えたフラスコに、GEMA60.0g、製造例2の疎水性モノマー48.0g、メトキシポリエチレングリコール(23)モノメタクリレート(商品名「ブレンマーPME−1000」日本油脂(株)製)12.0g、エチルアルコール300mlと0.05M炭酸ナトリウム水溶液30ml及び0.1M炭酸水素ナトリウム溶液270mlを採り攪拌混合した。攪拌を続けながら、1時間窒素ガス置換を行った。これに過硫酸アンモニウム2.0gを水20mlに溶解した溶液を加え、更に攪拌を続けながら、60℃で20時間反応を行った。反応終了後、水酸化ナトリウム水溶液を用いてpHを7.0に調整し、ロータリーエバポレーターでエチルアルコールを除去し、本発明のコポリマー2の水溶液を得た。
<Production Example 8>
In a flask equipped with a nitrogen inlet tube, a condenser and a stirrer, 60.0 g of GEMA, 48.0 g of the hydrophobic monomer of Production Example 2, methoxypolyethylene glycol (23) monomethacrylate (trade name “Blemmer PME-1000” Nippon Oil & Fats ( 12.0 g, 300 ml of ethyl alcohol, 30 ml of 0.05 M aqueous sodium carbonate solution and 270 ml of 0.1 M sodium hydrogen carbonate solution were taken and mixed with stirring. While stirring was continued, nitrogen gas substitution was performed for 1 hour. A solution obtained by dissolving 2.0 g of ammonium persulfate in 20 ml of water was added thereto, and the reaction was further performed at 60 ° C. for 20 hours while continuing stirring. After completion of the reaction, the pH was adjusted to 7.0 using an aqueous sodium hydroxide solution, and ethyl alcohol was removed using a rotary evaporator to obtain an aqueous solution of copolymer 2 of the present invention.
<製造例9>
窒素導入管、冷却器及び攪拌装置を備えたフラスコに、GEA48.0g、製造例3の疎水性モノマー36.0g、メトキシポリエチレングリコール(9)メタクリレート(日本油脂(株)製、商品名「ブレンマーPME−400」)24.0g、2−ヒドロキシエチルメタクリレート(東京化成工業(株)製)12.0g、イソプロピルアルコール300ml、0.2M塩化カリウム水溶液75ml、0.2N塩酸15.8ml及び水209.2mlを採り攪拌混合した。攪拌を続けながら、1時間窒素ガス置換を行った。これに過硫酸アンモニウム2.0gを水20mlに溶解した溶液を加え、更に攪拌を続けながら、70℃で14時間反応を行った。反応終了後、水酸化カリウム水溶液を用いてpHを7.0に調整し、ロータリーエバポレーターでイソプロピルアルコールを除去し、本発明のコポリマー3の水溶液を得た。
<Production Example 9>
In a flask equipped with a nitrogen inlet tube, a condenser and a stirrer, 48.0 g of GEA, 36.0 g of the hydrophobic monomer of Production Example 3, methoxypolyethylene glycol (9) methacrylate (manufactured by NOF Corporation, trade name “Blemmer PME” -400 ") 24.0 g, 2-hydroxyethyl methacrylate (manufactured by Tokyo Chemical Industry Co., Ltd.) 12.0 g, isopropyl alcohol 300 ml, 0.2 M aqueous potassium chloride solution 75 ml, 0.2 N hydrochloric acid 15.8 ml and water 209.2 ml Was mixed with stirring. While stirring was continued, nitrogen gas substitution was performed for 1 hour. A solution prepared by dissolving 2.0 g of ammonium persulfate in 20 ml of water was added thereto, and the reaction was performed at 70 ° C. for 14 hours while continuing stirring. After completion of the reaction, the pH was adjusted to 7.0 using an aqueous potassium hydroxide solution, and isopropyl alcohol was removed using a rotary evaporator to obtain an aqueous solution of copolymer 3 of the present invention.
<製造例10>
窒素導入管、冷却器及び攪拌装置を備えたフラスコに、GEA48.0g、製造例4の疎水性モノマー48.0g、アクリル酸(東京化成工業(株)製)24.0g、エチレングリコールモノメチルエーテル180ml及び0.002N塩酸120mを採り攪拌混合した。攪拌を続けながら、1時間窒素ガス置換を行った。これに過硫酸アンモニウム1.0gを水10mlに溶解した溶液を加え、更に攪拌を続けながら、65℃で16時間反応を行った。反応終了後、水酸化カリウム水溶液を用いてpHを7.0に調整し、ロータリーエバポレーターでエチレングリコールモノメチルエーテルを除去し、本発明のコポリマー4の水溶液を得た。
<Production Example 10>
In a flask equipped with a nitrogen inlet tube, a condenser and a stirrer, 48.0 g of GEA, 48.0 g of the hydrophobic monomer of Production Example 4, 24.0 g of acrylic acid (manufactured by Tokyo Chemical Industry Co., Ltd.), 180 ml of ethylene glycol monomethyl ether Then, 120 m of 0.002N hydrochloric acid was taken and mixed with stirring. While stirring was continued, nitrogen gas substitution was performed for 1 hour. A solution prepared by dissolving 1.0 g of ammonium persulfate in 10 ml of water was added thereto, and the reaction was continued at 65 ° C. for 16 hours while continuing stirring. After completion of the reaction, the pH was adjusted to 7.0 using an aqueous potassium hydroxide solution, and ethylene glycol monomethyl ether was removed with a rotary evaporator to obtain an aqueous solution of the copolymer 4 of the present invention.
<製造例11>
窒素導入管、冷却器及び攪拌装置を備えたフラスコに、GEMA72.0g、製造例6の疎水性モノマー48.0g、イソプロピルアルコール300ml、りん酸塩緩衝溶液(pH6.8)(ナカライテスク(株)製)300mlを採り攪拌混合した。攪拌を続けながら、1時間窒素ガス置換を行った。これに過硫酸アンモニウム2.0gを水20mlに溶解した溶液を加え、更に攪拌を続けながら、65℃で16時間反応を行った。反応終了後、水酸化ナトリウム水溶液を用いてpHを7.0に調整し、ロータリーエバポレーターでイソプロピルアルコールを除去し、本発明のコポリマー5の水溶液を得た。
<Production Example 11>
In a flask equipped with a nitrogen inlet tube, a condenser and a stirrer, 72.0 g of GEMA, 48.0 g of the hydrophobic monomer of Production Example 6, 300 ml of isopropyl alcohol, phosphate buffer solution (pH 6.8) (Nacalai Tesque) 300 ml) was taken and mixed with stirring. While stirring was continued, nitrogen gas substitution was performed for 1 hour. A solution prepared by dissolving 2.0 g of ammonium persulfate in 20 ml of water was added thereto, and the reaction was continued at 65 ° C. for 16 hours while continuing stirring. After completion of the reaction, the pH was adjusted to 7.0 using an aqueous sodium hydroxide solution, and isopropyl alcohol was removed using a rotary evaporator to obtain an aqueous solution of copolymer 5 of the present invention.
<製造例12>
窒素導入管、冷却器及び攪拌装置を備えたフラスコに、GEA60.0g,製造例1の疎水性モノマー48.0g、ポリエチレングリコール(9)モノメタクリレート(日本油脂(株)製、商品名「ブレンマーPE−400」)12.0g、酢酸エチル180ml及びエチルアルコールを採り攪拌混合した。攪拌を続けながら、1時間窒素ガス置換を行った。これに過酸化ベンゾイル0.5gをエチルアルコール10mlに溶解した溶液を加え、更に攪拌を続けながら、8時間、リフラックスを行った。反応終了後、2−エチルヘキサン酸トリグリセリル300gを添加し、ロータリーエバポレーターで酢酸エチル及びエチルアルコールを除去し、本発明のコポリマー6の2−エチルヘキサン酸トリグリセリル溶液を得た。
<Production Example 12>
In a flask equipped with a nitrogen inlet tube, a condenser and a stirrer, 60.0 g of GEA, 48.0 g of the hydrophobic monomer of Production Example 1, polyethylene glycol (9) monomethacrylate (manufactured by NOF Corporation, trade name “Blemmer PE” -400 ") 12.0 g, ethyl acetate 180 ml and ethyl alcohol were taken and mixed with stirring. While stirring was continued, nitrogen gas substitution was performed for 1 hour. A solution obtained by dissolving 0.5 g of benzoyl peroxide in 10 ml of ethyl alcohol was added thereto, and reflux was performed for 8 hours while continuing stirring. After completion of the reaction, 300 g of triglyceryl 2-ethylhexanoate was added, and ethyl acetate and ethyl alcohol were removed with a rotary evaporator to obtain a triglyceryl 2-ethylhexanoate solution of copolymer 6 of the present invention.
<製造例13>(比較例)
窒素導入管、冷却器及び攪拌装置を備えたフラスコに、GEMA72.0g、2−エチルへキシルメタクリレート(東京化成工業(株)製)48.0g、イソプロピルアルコール300ml、りん酸塩緩衝溶液(pH6.8)(ナカライテスク(株)製)300mlを採り攪拌混合した。攪拌を続けながら、1時間窒素ガス置換を行った。これに過硫酸アンモニウム2.0gを水20mlに溶解した溶液を加え、更に攪拌を続けながら、65℃で16時間反応を行った。反応終了後、水酸化ナトリウム水溶液を用いてpHを7.0に調整し、ロータリーエバポレーターでイソプロピルアルコールを除去し、コポリマー7の水溶液を得た。
<Production Example 13> (Comparative Example)
In a flask equipped with a nitrogen introduction tube, a condenser and a stirrer, 72.0 g of GEMA, 48.0 g of 2-ethylhexyl methacrylate (manufactured by Tokyo Chemical Industry Co., Ltd.), 300 ml of isopropyl alcohol, phosphate buffer solution (pH 6. 8) 300 ml (manufactured by Nacalai Tesque) was taken and mixed with stirring. While stirring was continued, nitrogen gas substitution was performed for 1 hour. A solution prepared by dissolving 2.0 g of ammonium persulfate in 20 ml of water was added thereto, and the reaction was continued at 65 ° C. for 16 hours while continuing stirring. After completion of the reaction, the pH was adjusted to 7.0 using an aqueous sodium hydroxide solution, and isopropyl alcohol was removed using a rotary evaporator to obtain an aqueous solution of copolymer 7.
<製造例14>(比較例)
窒素導入管、冷却器及び攪拌装置を備えたフラスコに、GEMA72.0g、ステアリルメタクリレート(東京化成工業(株)製)48.0g、イソプロピルアルコール300ml、水300mlを採り攪拌混合した。攪拌を続けながら、1時間窒素ガス置換を行った。これに過硫酸アンモニウム2.0gを水20mlに溶解した溶液を加え、更に攪拌を続けながら、65℃で16時間反応を行った。反応終了後、水酸化ナトリウム水溶液を用いてpHを7.0に調整し、ロータリーエバポレーターでイソプロピルアルコールを除去し、コポリマー8の水溶液を得た。
<Production Example 14> (Comparative Example)
GEMA 72.0 g, stearyl methacrylate (manufactured by Tokyo Kasei Kogyo Co., Ltd.) 48.0 g, isopropyl alcohol 300 ml, and water 300 ml were mixed in a flask equipped with a nitrogen inlet tube, a cooler, and a stirrer. While stirring was continued, nitrogen gas substitution was performed for 1 hour. A solution prepared by dissolving 2.0 g of ammonium persulfate in 20 ml of water was added thereto, and the reaction was continued at 65 ° C. for 16 hours while continuing stirring. After completion of the reaction, the pH was adjusted to 7.0 using an aqueous sodium hydroxide solution, and isopropyl alcohol was removed using a rotary evaporator to obtain an aqueous solution of copolymer 8.
<6>本発明の皮膚外用剤
本発明の外用剤は、前記、構成単位I及び構成単位IIを必須構成単位として含有し、場合により、親水性のモノマーから誘導される構成単位、その他のモノマーから誘導される構成単位を任意の構成単位として含有するコポリマーを必須成分として含有する。
<6> External preparation for skin of the present invention The external preparation of the present invention contains the structural unit I and the structural unit II as essential structural units, and in some cases, structural units derived from hydrophilic monomers, other monomers The copolymer which contains the structural unit derived from as an arbitrary structural unit is contained as an essential component.
本発明の皮膚外用剤における、該コポリマーの含有量は、好ましくは、0.5〜25質量%、さらに好ましくは、1〜15質量%である。下限値以下では本発明の効果が発揮されない場合があり好ましくない。また、上限値以上では、皮膚外用剤構成成分、特に水への溶解性が低く、コポリマーを均一に含有する皮膚外用剤の調製が困難である場合があり好ましくない。 The content of the copolymer in the external preparation for skin of the present invention is preferably 0.5 to 25% by mass, more preferably 1 to 15% by mass. Below the lower limit, the effect of the present invention may not be exhibited, which is not preferable. On the other hand, when the amount is not less than the upper limit value, it is not preferable because the preparation for the external preparation for skin, particularly the solubility in water, is low, and the preparation of the external preparation for skin containing the copolymer uniformly may be difficult.
本発明の皮膚外用剤としては、軟膏等の外用医薬品、化粧品等が好適に例示できる。さらに、化粧品としては、クリーム、乳液、化粧水、美容液等のスキンケア、アンダーメーク、ファンデーション、アイカラー、マスカラ等のメークアップ、へアトニック、ヘアリキッド、ヘアスプレー等の毛髪化粧料等が例示できる。 As an external preparation for skin of the present invention, external medicines such as ointments, cosmetics and the like can be suitably exemplified. Furthermore, examples of cosmetics include skin care such as cream, milky lotion, skin lotion, and beauty serum, make-up such as under makeup, foundation, eye color, and mascara, and hair cosmetics such as hair tonic, hair liquid, and hair spray. .
本発明の皮膚外用剤は発明の効果を損なわない範囲で、通常、皮膚外用剤に使用する、成分を、任意成分として含有することができる。かかる任意成分としては、具体的に、
マカデミアナッツ油、アボガド油、トウモロコシ油、オリーブ油、ナタネ油、ゴマ油、ヒマシ油、サフラワー油、綿実油、ホホバ油、ヤシ油、パーム油、液状ラノリン、硬化ヤシ油、硬化油、モクロウ、硬化ヒマシ油、ミツロウ、キャンデリラロウ、カルナウバロウ、イボタロウ、ラノリン、還元ラノリン、硬質ラノリン、ホホバロウ等のオイル、ワックス類、流動パラフィン、スクワラン、プリスタン、オゾケライト、パラフィン、セレシン、ワセリン、マイクロクリスタリンワックス等の炭化水素類、オレイン酸、イソステアリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、ウンデシレン酸等の高級脂肪酸類、セチルアルコール、ステアリルアルコール、イソステアリルアルコール、ベヘニルアルコール、オクチルドデカノール、ミリスチルアルコール、セトステアリルアルコール等の高級アルコール等、イソオクタン酸セチル、ミリスチン酸イソプロピル、イソステアリン酸ヘキシルデシル、アジピン酸ジイソプロピル、セバチン酸ジ−2−エチルヘキシル、乳酸セチル、リンゴ酸ジイソステアリル、ジ−2−エチルヘキサン酸エチレングリコール、ジカプリン酸ネオペンチルグリコール、ジ−2−ヘプチルウンデカン酸グリセリン、トリ−2−エチルヘキサン酸グリセリン、トリ−2−エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ−2−エチルヘキサン酸ペンタンエリトリット等の合成エステル油類、ジメチルポリシロキサン、メチルフェニルポリシロキサン、ジフェニルポリシロキサン等の鎖状ポリシロキサン、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサンシロキサン等の環状ポリシロキサン、アミノ変性ポリシロキサン、ポリエーテル変性ポリシロキサン、アルキル変性ポリシロキサン、フッ素変性ポリシロキサン等の変性ポリシロキサン等のシリコーン油等の油剤類、脂肪酸セッケン(ラウリン酸ナトリウム、パルミチン酸ナトリウム等)、ラウリル硫酸カリウム、アルキル硫酸トリエタノールアミンエーテル等のアニオン界面活性剤類、塩化ステアリルトリメチルアンモニウム、塩化ベンザルコニウム、ラウリルアミンオキサイド等のカチオン界面活性剤類、イミダゾリン系両性界面活性剤(2−ココイル−2−イミダゾリニウムヒドロキサイド−1−カルボキシエチロキシ2ナトリウム塩等)、ベタイン系界面活性剤(アルキルベタイン、アミドベタイン、スルホベタイン等)、アシルメチルタウリン等の両性界面活性剤類、ソルビタン脂肪酸エステル類(ソルビタンモノステアレート、セスキオレイン酸ソルビタン等)、グリセリン脂肪酸類(モノステアリン酸グリセリン等)、プロピレングリコール脂肪酸エステル類(モノステアリン酸プロピレングリコール等)、硬化ヒマシ油誘導体、POEソルビタン脂肪酸エステル類(POEソルビタンモノオレエート、モノステアリン酸ポリオキエチレンソルビタン等)、POEソルビット脂肪酸エステル類(POE−ソルビットモノラウレート等)、POEグリセリン脂肪酸エステル類(POE−グリセリンモノイソステアレート等)、POE脂肪酸エステル類(ポリエチレングリコールモノオレート、POEジステアレート等)、POEアルキルエーテル類(POE2−オクチルドデシルエーテル等)、POEアルキルフェニルエーテル類(POEノニルフェニルエーテル等)、プルロニック型類、POE・POPアルキルエーテル類(POE・POP2−デシルテトラデシルエーテル等)、テトロニック類、POEヒマシ油・硬化ヒマシ油誘導体(POEヒマシ油、POE硬化ヒマシ油等)、ショ糖脂肪酸エステル、アルキルグルコシド等の非イオン界面活性剤類、ポリエチレングリコール、グリセリン、1,3−ブチレングリコール、エリスリトール、ソルビトール、キシリトール、マルチトール、プロピレングリコール、ジプロピレングリコール、ジグリセリン、イソプレングリコール、1,2−ペンタンジオール、2,4−ヘキシレングリコール、1,2−ヘキサンジオール、1,2−オクタンジオール等の多価アルコール類、ピロリドンカルボン酸ナトリウム、乳酸、乳酸ナトリウム等の保湿成分類、グアガム、クインスシード、カラギーナン、ガラクタン、アラビアガム、ペクチン、マンナン、デンプン、キサンタンガム、カードラン、メチルセルロース、ヒドロキシエチルセルロース、カルボキシメチルセルロース、メチルヒドロキシプロピルセルロース、コンドロイチン硫酸、デルマタン硫酸、グリコーゲン、ヘパラン硫酸、ヒアルロン酸、ヒアルロン酸ナトリウム、トラガントガム、ケラタン硫酸、コンドロイチン、ムコイチン硫酸、ヒドロキシエチルグアガム、カルボキシメチルグアガム、デキストラン、ケラト硫酸,ローカストビーンガム,サクシノグルカン,カロニン酸,キチン,キトサン、カルボキシメチルキチン、寒天、ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー、ポリアクリル酸ナトリウム、ポリエチレングリコール、ベントナイト等の増粘剤、エタノール、イソプロパノール等の低級アルコール類、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル及、t−ブチルメトキシベンゾイルメタン、パラアミノ安息香酸系紫外線吸収剤、アントラニル酸系紫外線吸収剤、サリチル酸系紫外線吸収剤、桂皮酸系紫外線吸収剤等の紫外線吸収剤、ビタミンA又はその誘導体、ビタミンB6塩酸塩,ビタミンB6トリパルミテート,ビタミンB6ジオクタノエート,ビタミンB2又はその誘導体,ビタミンB12,ビタミンB15又はその誘導体等のビタミンB類、α−トコフェロール,β−トコフェロール,γ−トコフェロール,ビタミンEアセテート等のビタミンE類、ビタミンD類、ビタミンH、パントテン酸、パンテチン、ピロロキノリンキノン等のビタミン類などが好ましく例示できる。
The external preparation for skin of the present invention can contain, as an optional component, components that are usually used for external preparations for skin as long as the effects of the invention are not impaired. As such optional components, specifically,
Macadamia nut oil, avocado oil, corn oil, olive oil, rapeseed oil, sesame oil, castor oil, safflower oil, cottonseed oil, jojoba oil, coconut oil, palm oil, liquid lanolin, hydrogenated coconut oil, hydrogenated oil, molasses, hydrogenated castor oil, Oils such as beeswax, candelilla wax, carnauba wax, ibotarou, lanolin, reduced lanolin, hard lanolin, jojoba wax, waxes, liquid paraffin, squalane, pristane, ozokerite, paraffin, ceresin, petrolatum, hydrocarbons such as microcrystalline wax, Higher fatty acids such as oleic acid, isostearic acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, undecylenic acid, cetyl alcohol, stearyl alcohol, isostearyl alcohol, behenyl alcohol, Higher alcohols such as cutyldecanol, myristyl alcohol, cetostearyl alcohol, etc., cetyl isooctanoate, isopropyl myristate, hexyldecyl isostearate, diisopropyl adipate, di-2-ethylhexyl sebacate, cetyl lactate, diisostearyl malate, Di-2-ethylhexanoic acid ethylene glycol, dicaprate neopentyl glycol, di-2-heptylundecanoic acid glycerin, tri-2-ethylhexanoic acid glycerin, tri-2-ethylhexanoic acid trimethylolpropane, triisostearic acid trimethylol Synthetic ester oils such as propane, tetra-2-ethylhexanoic acid pentane erythritol, dimethylpolysiloxane, methylphenylpolysiloxane, diphenylpolysiloxane Linear polysiloxanes such as, cyclic polysiloxanes such as octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexanesiloxane, amino-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxane, fluorine-modified polysiloxane, etc. Oils such as silicone oils such as modified polysiloxanes, fatty acid soaps (sodium laurate, sodium palmitate, etc.), anionic surfactants such as potassium lauryl sulfate, alkylethanol triethanolamine ether, stearyltrimethylammonium chloride, chloride Cationic surfactants such as benzalkonium and laurylamine oxide, imidazoline-based amphoteric surfactants (2-cocoyl-2-imidazolinium hydroxide-1-cal Boxyethyloxy disodium salt, etc.), betaine surfactants (alkyl betaine, amide betaine, sulfobetaine, etc.), amphoteric surfactants such as acylmethyltaurine, sorbitan fatty acid esters (sorbitan monostearate, sorbitan sesquioleate, etc.) ), Glycerin fatty acids (such as glyceryl monostearate), propylene glycol fatty acid esters (such as propylene glycol monostearate), hydrogenated castor oil derivatives, POE sorbitan fatty acid esters (POE sorbitan monooleate, polyoxyethylene monostearate) Sorbitan, etc.), POE sorbite fatty acid esters (POE-sorbite monolaurate, etc.), POE glycerin fatty acid esters (POE-glycerol monoisostearate, etc.), POE fat Acid esters (polyethylene glycol monooleate, POE distearate, etc.), POE alkyl ethers (POE2-octyldodecyl ether, etc.), POE alkyl phenyl ethers (POE nonylphenyl ether, etc.), Pluronic types, POE / POP alkyl ethers (POE / POP2-decyltetradecyl ether, etc.), Tetronics, POE castor oil / hardened castor oil derivatives (POE castor oil, POE hardened castor oil, etc.), nonionic surfactants such as sucrose fatty acid ester, alkyl glucoside Polyethylene glycol, glycerin, 1,3-butylene glycol, erythritol, sorbitol, xylitol, maltitol, propylene glycol, dipropylene glycol, diglycerin, isoprene Moisturizing composition of polyalcohols such as coal, 1,2-pentanediol, 2,4-hexylene glycol, 1,2-hexanediol, 1,2-octanediol, sodium pyrrolidonecarboxylate, lactic acid, sodium lactate Classification, guar gum, quince seed, carrageenan, galactan, gum arabic, pectin, mannan, starch, xanthan gum, curdlan, methylcellulose, hydroxyethylcellulose, carboxymethylcellulose, methylhydroxypropylcellulose, chondroitin sulfate, dermatan sulfate, glycogen, heparan sulfate, hyaluron Acid, sodium hyaluronate, tragacanth gum, keratan sulfate, chondroitin, mucoitin sulfate, hydroxyethyl guar gum, carboxymethyl guar gum, dextran , Keratosulfuric acid, locust bean gum, succinoglucan, caronic acid, chitin, chitosan, carboxymethyl chitin, agar, polyvinyl alcohol, polyvinyl pyrrolidone, carboxyvinyl polymer, sodium polyacrylate, polyethylene glycol, bentonite and other thickeners, Lower alcohols such as ethanol and isopropanol, hexyl diethylaminohydroxybenzoylbenzoate, t-butylmethoxybenzoylmethane, paraaminobenzoic acid UV absorber, anthranilic acid UV absorber, salicylic acid UV absorber, cinnamic acid UV absorber UV absorbers, vitamin A or its derivatives, vitamin B6 hydrochloride, vitamin B6 tripalmitate, vitamin B6 dioctanoate, vitamin B2 or its derivatives, vitamin B12, vitamin B15 such as vitamin B15 or derivatives thereof, α-tocopherol, β-tocopherol, γ-tocopherol, vitamin E such as vitamin E acetate, vitamin D, vitamin H, pantothenic acid, panthetin, pyrroloquinoline quinone, etc. Of these, vitamins can be preferably exemplified.
本発明の皮膚外用剤は、上記必須成分と任意成分とを常法によって処理することにより、調製することができる。 The external preparation for skin of the present invention can be prepared by treating the above essential components and optional components by a conventional method.
以下、実施例を挙げて本発明を具体的に説明するが、本発明がこれら実施例にのみ限定されないことは言うまでもない。 EXAMPLES Hereinafter, although an Example is given and this invention is demonstrated concretely, it cannot be overemphasized that this invention is not limited only to these Examples.
<実施例1〜3、比較例1〜3>
表2記載の成分を攪拌混合し、均一透明溶液が得られるまで室温で攪拌を続けて、本発明の化粧水及び比較例の化粧水を得た。なお、表中の数字は質量%を意味する。
<Examples 1-3, Comparative Examples 1-3>
The ingredients listed in Table 2 were stirred and mixed, and stirring was continued at room temperature until a uniform transparent solution was obtained, thereby obtaining the lotion of the present invention and the lotion of the comparative example. In addition, the number in a table | surface means the mass%.
<試験例1>皮膚バリアー機能向上作用の評価
経表皮水分喪失(TEWL)(TEWAMETER TM210:courage+khazaka製を用いて測定)の測定値が30(g/m2hr)以上のパネラーを皮膚バリアー機能が低下しているパネルとして選択し、実施例1〜3、比較例1〜3の化粧水を肌に塗布した場合の皮膚バリアー機能向上作用を評価した。
<Test Example 1> Evaluation of Skin Barrier Function Improvement Action Transepidermal water loss (TEWL) (measured using TEWAMETER TM210: curation + khazaka) is a panel having a skin barrier function of 30 (g / m 2 hr) or more. It selected as the panel which has fallen, and evaluated the skin barrier function improvement effect at the time of apply | coating the skin lotion of Examples 1-3 and Comparative Examples 1-3 to skin.
朝晩二回、7日間連続で化粧水を腕の塗布部位に塗布した。化粧水塗布試験開始前と7日間塗布を行った時点で乳酸0.01質量%水溶液を化粧水塗布部位に塗布し、感じる刺激を以下の3段階の刺激防御スコアーとして評価し、両者を比較することで皮膚バリアー機能向上効果を評価した。刺激防御スコアーは10名のパネラーの刺激防御スコアーの平均値とした。結果を表3に示す。なお、刺激防御スコアーが高いほど刺激を感じにくい、すなわち、皮膚バリアー機能が高いことを意味する。
刺激防御スコアー:1点 刺激をかなり感じる。
2点 刺激をやや感じる。
3点 刺激をわずかに感じる。
4点 刺激をほとんど感じない。
5点 刺激を全く感じない。
Lotion was applied to the application site of the arm twice in the morning and evening for 7 consecutive days. Apply a 0.01% by weight lactic acid aqueous solution to the skin lotion application site before the start of the skin lotion application test and when applied for 7 days, evaluate the irritation felt as the following three levels of stimulation protection scores, and compare the two Thus, the skin barrier function improving effect was evaluated. The stimulation defense score was the average of the stimulation defense scores of 10 panelists. The results are shown in Table 3. In addition, it means that irritation | stimulation is hard to feel, that is, a skin barrier function is so high that a stimulation defense score is high.
Stimulation defense score: 1 point I feel a lot of stimulation.
2 points I feel some stimulation.
3 points I feel slight irritation.
4 points I hardly feel any irritation.
5 points I do not feel any stimulation.
<試験例2>動摩擦係数の測定
人肌類似のポリウレタン製合成皮革(試験前に予めエタノールで表面を清潔にしておく)の短冊(15cm×5cm)上の長手方向の端から1cmで、3cm×3cmの範囲に、実施例1〜3の化粧水及び比較例1〜3の化粧水20mgを均一に塗布し、両面テープで実験台に固定する。一方、同じ合成皮革片3cm×3cmを、荷重を載せる治具に両面テープで貼り付けておく。前記試料の塗布面に、上記治具を合成皮革の面を対向させて載置し、荷重200gを載せ、表面性試験機(トリラボ ハンディーラブテスター Type TL701)にて摩擦抵抗を測定した。測定条件は、掃引速度200mm/sec、掃引距離10cm、リピート回数10回とし、往路の10回の摩擦抵抗値の平均を動摩擦抵抗値とした。動摩擦係数は、動摩擦抵抗値÷荷重にて算出した。動摩擦係数が小さいほど、滑りに対する抵抗が無いことを表す。結果を表3に示す。
<Test Example 2> Measurement of dynamic friction coefficient 1 cm from the longitudinal end of a strip (15 cm × 5 cm) of a synthetic leather made of polyurethane similar to human skin (previously cleaned with ethanol before the test), 3 cm × 3 cm × In the range of 3 cm, the skin lotions of Examples 1 to 3 and the skin lotions of Comparative Examples 1 to 3 are uniformly applied and fixed to the experimental table with double-sided tape. On the other hand, the same synthetic leather piece 3 cm × 3 cm is attached to a jig for placing a load with double-sided tape. The jig was placed on the coated surface of the sample so that the surface of the synthetic leather faced, a load of 200 g was placed, and the frictional resistance was measured with a surface property tester (Trilab Handy Love Tester Type TL701). The measurement conditions were a sweep speed of 200 mm / sec, a sweep distance of 10 cm, a repeat count of 10 times, and the average of the 10 frictional resistance values in the forward path was defined as the dynamic frictional resistance value. The dynamic friction coefficient was calculated by dynamic friction resistance value / load. A smaller dynamic friction coefficient indicates that there is no resistance to slipping. The results are shown in Table 3.
<試験例3>塗布膜の柔軟性の評価
実施例1〜3,比較例1〜3の化粧水を厚さ0.1mmのスチレンフィルム上に塗布し、80℃で4時間乾燥をおこなって、試験片を作成した。この試験片を、前後に折り曲げ、塗布膜表面にクラックが生じる折り曲げ回数を測定し、塗布膜の柔軟性とした。回数が多いほど、被膜が柔軟であることを表す。結果を表3に示す。
<Test Example 3> Evaluation of flexibility of coating film The skin lotions of Examples 1 to 3 and Comparative Examples 1 to 3 were applied on a styrene film having a thickness of 0.1 mm and dried at 80 ° C. for 4 hours. A test piece was prepared. This test piece was bent back and forth, and the number of bendings at which cracks occurred on the surface of the coating film was measured to determine the flexibility of the coating film. The greater the number of times, the more flexible the coating. The results are shown in Table 3.
<試験例4>
熟練評価者5名により、実施例1〜3の化粧水及び比較例1〜3の化粧水の使用中のきしみ及び使用後のつっぱり感を以下の評価基準で官能評価した。
つっぱり感 1:つっぱり感をかなり感じる、2:つっぱり感を感じる、3:つっぱり感をやや感じる、4:つっぱり感をごくわずかに感じる、5:つっぱり感を全く感じない。
きしみ 1:きしみをかなり感じる、2:きしみを感じる、3:きしみをやや感じる、4:きしみをごくわずかに感じる、5:きしみを全く感じない。
なお、評価は比較例1の化粧水の評点を3.0としておこない、5名の評点の平均値をサンプルの評点とした。結果を表3に示す。
<Test Example 4>
By five skilled evaluators, the squeak during use of the lotions of Examples 1 to 3 and the lotions of Comparative Examples 1 to 3 and sensory feeling after use were subjected to sensory evaluation according to the following evaluation criteria.
Feeling tight 1: Feeling quite tight 2: Feeling tight 3: Feeling a little bit 4: Feeling a little bit felt 5: Feeling nothing at all
Squeak 1: Feels squeak fairly 2: Feels squeak 3: Feels squeak slightly 4: Feels squeak slightly 5: Does not feel squeak at all
In addition, evaluation was performed by setting the skin lotion of Comparative Example 1 to 3.0, and the average value of the scores of 5 people was used as the sample score. The results are shown in Table 3.
<実施例4〜6、比較例4〜6>
表4の処方に基づいて本発明の皮膚外用剤である乳液と、比較例の乳液を作成した。すなわち、表4の成分(イ)を75℃に加熱攪拌混合溶解し、これに、攪拌をおこないながら、成分(ロ)を75℃に加熱混合溶解した溶液を徐々に添加し乳化した。その後、冷却をおこない、40℃になったら、成分(ハ)を混合溶解した溶液を添加し、室温まで冷却し、乳液を得た。なお、表中の数字は質量%を意味する。得られた実施例4〜6の乳液、比較例4〜6の乳液に関しても試験例1〜4と同様の方法で、皮膚バリアー機能の向上作用、塗布膜のそう摩擦係数、柔軟性、使用中のきしみ、使用後のつっぱり感(比較例4を3点とした。)を評価した。結果を表5に示す。
<Examples 4-6, Comparative Examples 4-6>
Based on the formulation in Table 4, an emulsion that is an external preparation for skin of the present invention and an emulsion of a comparative example were prepared. That is, the component (I) in Table 4 was heated and mixed with dissolution at 75 ° C., and a solution in which the component (B) was heated and mixed at 75 ° C. was gradually added and emulsified while stirring. Then, it cooled and when it became 40 degreeC, the solution which mixed and dissolved the component (c) was added, it cooled to room temperature, and the emulsion was obtained. In addition, the number in a table | surface means the mass%. Regarding the obtained emulsions of Examples 4 to 6 and the emulsions of Comparative Examples 4 to 6, in the same manner as in Test Examples 1 to 4, the effect of improving the skin barrier function, the coefficient of friction of the coating film, the flexibility, and in use The squeakiness and the feeling of tension after use (comparative example 4 was 3 points) were evaluated. The results are shown in Table 5.
<実施例7〜9 比較例7〜9>
表6の処方にしたがって、本発明の皮膚外用剤である、ファンデーションを作成した。すなわち、成分(イ)を75℃に加熱、混合溶解した後、これに成分(ロ)をディスパーを用いて分散した。これに、攪拌をおこないながら、成分(ハ)を75℃に加熱溶解した溶液を徐々に添加して乳化をおこなった後、攪拌を続けて室温まで冷却し、ファンデーションを得た。なお、表中の数字は質量%を意味する。得られた実施例7〜9のファンデーション、比較例7〜9のファンデーションに関しても試験例1〜4と同様の方法で、皮膚バリアー機能の向上作用、塗布膜のそう摩擦係数、柔軟性、使用中のきしみ、使用後のつっぱり感(比較例7を3点とした。)を評価した。結果を表7に示す。
<Examples 7-9 Comparative Examples 7-9>
According to the formulation of Table 6, a foundation, which is an external preparation for skin of the present invention, was prepared. That is, after component (a) was heated to 75 ° C., mixed and dissolved, component (b) was dispersed therein using a disper. While stirring, a solution in which the component (c) was heated and dissolved at 75 ° C. was gradually added to emulsify, and then stirring was continued to cool to room temperature to obtain a foundation. In addition, the number in a table | surface means the mass%. Regarding the foundations of Examples 7 to 9 and the foundations of Comparative Examples 7 to 9 that were obtained, the same method as in Test Examples 1 to 4, was used to improve the skin barrier function, the coefficient of friction of the coating film, the flexibility, and in use The creaking and the feeling of tension after use (comparative example 7 was set to 3 points) were evaluated. The results are shown in Table 7.
本発明は、化粧料などに使用される。 The present invention is used for cosmetics and the like.
Claims (6)
一般式(I)
(一般式(I)中R1は水素原子またはメチル基を、G−O−は還元糖の1位の水酸基より水素を除いた基を表す。nは2又は3を、mは1〜5の整数を表す。)
一般式(II)
(一般式(II)中R2は水素原子または炭素数1〜3のアルキル基を表し、R3は環構造を含まない、炭素数13〜30の分岐状炭化水素基、または、環構造を含まない、2つ以上の分岐を有する炭素数6〜12の炭化水素基を表す。) One or more structural units derived from a monomer represented by the following general formula (I), and one or more structural units derived from a hydrophobic monomer represented by the general formula (II) An external preparation for skin, comprising a copolymer having as an essential structural unit.
Formula (I)
(In general formula (I), R 1 represents a hydrogen atom or a methyl group, G—O— represents a group in which hydrogen is removed from the hydroxyl group at the 1-position of the reducing sugar, n is 2 or 3, and m is 1 to 5). Represents an integer.)
Formula (II)
(In General Formula (II), R 2 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R 3 represents a branched hydrocarbon group having 13 to 30 carbon atoms or a ring structure that does not include a ring structure. (A hydrocarbon group having 6 to 12 carbon atoms having two or more branches not included)
一般式(III)
(一般式(III)中R4は水素原子または炭素数1〜3のアルキル基を表し、R5は水酸基を有していてもよい炭素数2〜4のアルキレン基を表し、R6は水素原子、炭素数6〜10の芳香族炭化水素基、炭素数1〜14の脂肪族炭化水素基又は炭素数1〜12のアシル基を表す。pは4〜40の整数を表す。) Furthermore, the copolymer contains a structural unit derived from one or more monomers selected from the group consisting of a polymerizable carboxylic acid and a salt thereof, and a hydrophilic monomer represented by the following general formula (III). The external preparation for skin according to claim 1, wherein
Formula (III)
(In general formula (III), R 4 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R 5 represents an alkylene group having 2 to 4 carbon atoms which may have a hydroxyl group, and R 6 represents hydrogen. An atom, an aromatic hydrocarbon group having 6 to 10 carbon atoms, an aliphatic hydrocarbon group having 1 to 14 carbon atoms, or an acyl group having 1 to 12 carbon atoms, p represents an integer of 4 to 40.)
一般式(IV)
(一般式(IV)中R7は水素原子または炭素数1〜3のアルキル基を表し、R8は水素原子、炭素数6〜10の芳香族炭化水素基、炭素数1〜14の脂肪族炭化水素基又は炭素数1〜12のアシル基を表す。qは4〜40の整数を表す。) The external preparation for skin according to claim 2, wherein the hydrophilic monomer represented by the general formula (III) is a hydrophilic monomer represented by the following general formula (IV).
Formula (IV)
(In general formula (IV), R 7 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R 8 represents a hydrogen atom, an aromatic hydrocarbon group having 6 to 10 carbon atoms, or an aliphatic group having 1 to 14 carbon atoms. And represents a hydrocarbon group or an acyl group having 1 to 12 carbon atoms, q represents an integer of 4 to 40.)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012176586A JP5978058B2 (en) | 2012-08-09 | 2012-08-09 | Skin preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012176586A JP5978058B2 (en) | 2012-08-09 | 2012-08-09 | Skin preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2014034545A true JP2014034545A (en) | 2014-02-24 |
JP5978058B2 JP5978058B2 (en) | 2016-08-24 |
Family
ID=50283741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012176586A Active JP5978058B2 (en) | 2012-08-09 | 2012-08-09 | Skin preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5978058B2 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06122609A (en) * | 1992-10-12 | 1994-05-06 | Nippon Fine Chem Co Ltd | Additive for cosmetics or pharmaceuticals |
JP2001316422A (en) * | 2000-05-09 | 2001-11-13 | Pola Chem Ind Inc | Copolymer and cosmetic containing it |
JP2004107233A (en) * | 2002-09-17 | 2004-04-08 | Kuraray Co Ltd | Skin care preparation for external use |
JP2005008592A (en) * | 2003-06-20 | 2005-01-13 | Pola Chem Ind Inc | Cosmetic for retaining water content in horny cell layer |
-
2012
- 2012-08-09 JP JP2012176586A patent/JP5978058B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06122609A (en) * | 1992-10-12 | 1994-05-06 | Nippon Fine Chem Co Ltd | Additive for cosmetics or pharmaceuticals |
JP2001316422A (en) * | 2000-05-09 | 2001-11-13 | Pola Chem Ind Inc | Copolymer and cosmetic containing it |
JP2004107233A (en) * | 2002-09-17 | 2004-04-08 | Kuraray Co Ltd | Skin care preparation for external use |
JP2005008592A (en) * | 2003-06-20 | 2005-01-13 | Pola Chem Ind Inc | Cosmetic for retaining water content in horny cell layer |
Also Published As
Publication number | Publication date |
---|---|
JP5978058B2 (en) | 2016-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5978059B2 (en) | Skin preparation | |
JP6144465B2 (en) | Topical skin preparation | |
JP6144466B2 (en) | Topical skin preparation | |
KR20090087838A (en) | Oil-in-water type emulsified skin cosmetics showing a white cloudy phenomenon | |
JP5837330B2 (en) | Viscous composition | |
JP5972098B2 (en) | Skin preparation | |
JP2014114230A (en) | Oil-in-water type emulsified composition | |
JP5114089B2 (en) | Milky skin cosmetic | |
JP2013170154A (en) | Oil-in-water type emulsified skin cosmetic | |
JP2007161616A (en) | Skin care preparation | |
JP5851725B2 (en) | Water-based or oil-in-water emulsified makeup cosmetics | |
JP5978058B2 (en) | Skin preparation | |
JP5797507B2 (en) | Cosmetic composition | |
CN111329787B (en) | Copolymer | |
JP2005255526A (en) | Emulsified cosmetic | |
WO2022088065A1 (en) | Composition for conditioning keratin materials | |
JP2003012476A (en) | Semisolid hair cosmetic | |
JP6199443B2 (en) | Topical skin preparation | |
JP6608612B2 (en) | Copolymer | |
JP7100744B2 (en) | Emulsifying composition | |
JP4963873B2 (en) | Oil-in-water emulsion composition | |
JP4616815B2 (en) | A topical skin preparation that gives skin smoothness | |
JP2009143816A (en) | Skin care preparation | |
JP2016210919A (en) | Coated film having sea-island structure and composition forming the same | |
WO2022088054A1 (en) | Composition for conditioning keratin materials |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150730 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20150730 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20160414 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160510 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160719 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160725 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5978058 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |